<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:00:06Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4761979" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4761979</identifier><datestamp>2016-02-29</datestamp><setSpec>scirep</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
      <journal-title-group>
        <journal-title>Scientific Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2045-2322</issn>
      <publisher>
        <publisher-name>Nature Publishing Group</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4761979</article-id>
      <article-id pub-id-type="pmcid">PMC4761979</article-id>
      <article-id pub-id-type="pmc-uid">4761979</article-id>
      <article-id pub-id-type="pmid">26898943</article-id>
      <article-id pub-id-type="pii">srep21734</article-id>
      <article-id pub-id-type="doi">10.1038/srep21734</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Interplay of histidine residues of the Alzheimerâs disease AÎ² peptide governs its Zn-induced oligomerization</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Istrate</surname>
            <given-names>Andrey N.</given-names>
          </name>
          <xref ref-type="aff" rid="a1">1</xref>
          <xref ref-type="author-notes" rid="n1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kozin</surname>
            <given-names>Sergey A.</given-names>
          </name>
          <xref ref-type="aff" rid="a1">1</xref>
          <xref ref-type="author-notes" rid="n1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhokhov</surname>
            <given-names>Sergey S.</given-names>
          </name>
          <xref ref-type="aff" rid="a2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mantsyzov</surname>
            <given-names>Alexey B.</given-names>
          </name>
          <xref ref-type="aff" rid="a2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kechko</surname>
            <given-names>Olga I.</given-names>
          </name>
          <xref ref-type="aff" rid="a1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pastore</surname>
            <given-names>Annalisa</given-names>
          </name>
          <xref ref-type="aff" rid="a3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Makarov</surname>
            <given-names>Alexander A.</given-names>
          </name>
          <xref ref-type="aff" rid="a1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Polshakov</surname>
            <given-names>Vladimir I.</given-names>
          </name>
          <xref ref-type="corresp" rid="c1">a</xref>
          <xref ref-type="aff" rid="a2">2</xref>
        </contrib>
        <aff id="a1"><label>1</label><institution>Engelhardt Institute of Molecular Biology, Russian Academy of Sciences</institution>, 119991, Moscow, <country>Russia</country></aff>
        <aff id="a2"><label>2</label><institution>Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University</institution>, 119991, Moscow, <country>Russia</country></aff>
        <aff id="a3"><label>3</label><institution>The Wohl Institute, Kingâs College London</institution>, SE5 9RT, London, <country>UK</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">
          <label>a</label>
          <email>vpolsha@mail.ru</email>
        </corresp>
        <fn id="n1">
          <label>*</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>02</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>6</volume>
      <elocation-id>21734</elocation-id>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>01</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2016, Macmillan Publishers Limited</copyright-statement>
        <copyright-year>2016</copyright-year>
        <copyright-holder>Macmillan Publishers Limited</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <!--author-paid-->
          <license-p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the articleâs Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p>
        </license>
      </permissions>
      <abstract>
        <p>Conformational changes of AÎ² peptide result in its transformation from native monomeric state to the toxic soluble dimers, oligomers and insoluble aggregates that are hallmarks of Alzheimerâs disease (AD). Interactions of zinc ions with AÎ² are mediated by the N-terminal AÎ²<sub>1â16</sub> domain and appear to play a key role in AD progression. There is a range of results indicating that these interactions trigger the AÎ² plaque formation. We have determined structure and functional characteristics of the metal binding domains derived from several AÎ² variants and found that their zinc-induced oligomerization is governed by conformational changes in the minimal zinc binding site <sub>6</sub>HDSGYEVHH<sub>14</sub>. The residue H6 and segment <sub>11</sub>EVHH<sub>14</sub>, which are part of this site are crucial for formation of the two zinc-mediated interaction interfaces in AÎ². These structural determinants can be considered as promising targets for rational design of the AD-modifying drugs aimed at blocking pathological AÎ² aggregation.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p>According to the amyloid hypothesis, which has been the predominant framework for Alzheimer disease (AD) studies, AÎ² aggregation has a unique and critical role as an initiator of AD pathology<xref ref-type="bibr" rid="b1">1</xref><xref ref-type="bibr" rid="b2">2</xref>. What triggers AÎ² aggregation still remains unclear, however, some genetically and/or post-translationally modified AÎ² species accumulated in the amyloid plaques appear to act as the pathogenic aggregation seeds<xref ref-type="bibr" rid="b3">3</xref>. It has been shown in animal models of AD that zinc ions might play a crucial role in the AÎ² plaque formation <italic>in vivo</italic><xref ref-type="bibr" rid="b4">4</xref><xref ref-type="bibr" rid="b5">5</xref><xref ref-type="bibr" rid="b6">6</xref><xref ref-type="bibr" rid="b7">7</xref>. Indeed, at concentration as high as that detected in the synapse, zinc ions specifically bind AÎ² and are able to facilitate AÎ² aggregation<xref ref-type="bibr" rid="b8">8</xref>, which could explain abnormally high levels of zinc ions within amyloid plaques of AD patients<xref ref-type="bibr" rid="b9">9</xref><xref ref-type="bibr" rid="b10">10</xref>. It is assumed that zinc ions promote AÎ² aggregation via population shift of polymorphic states<xref ref-type="bibr" rid="b11">11</xref> with a mechanism similar to that observed for larger zinc-binding proteins<xref ref-type="bibr" rid="b12">12</xref>. When zinc-induced AÎ² amyloidogenesis is observed <italic>in vitro,</italic> conformational changes in AÎ² are also identified<xref ref-type="bibr" rid="b13">13</xref>. However, precise structural details of these changes were elusive since three-dimensional structures of AÎ² oligomers complexed with zinc ions were unavailable<xref ref-type="bibr" rid="b14">14</xref>.</p>
    <p>Interaction of Zn<sup>2+</sup> with monomeric AÎ² species is mediated by the metal binding domain which comprises the N-terminal region 1â16 of AÎ²<xref ref-type="bibr" rid="b15">15</xref><xref ref-type="bibr" rid="b16">16</xref><xref ref-type="bibr" rid="b17">17</xref>. AÎ²<sub>1â16</sub> exists in health and disease as a separate entity<xref ref-type="bibr" rid="b18">18</xref>, suggesting its possible role as the structural and functional unit of the full-length AÎ². Indeed, the interaction of N-terminal region 1â16 with the Î²-strand hydrophobic region 17- 42 is negligible in the model amyloid aggregates<xref ref-type="bibr" rid="b19">19</xref><xref ref-type="bibr" rid="b20">20</xref>, and also synthetic peptides AÎ²<sub>1â16</sub> exhaustively simulate the metal binding properties of AÎ²<xref ref-type="bibr" rid="b15">15</xref><xref ref-type="bibr" rid="b16">16</xref><xref ref-type="bibr" rid="b21">21</xref>. Previous NMR studies of the N-terminus of AÎ² showed that the first 9 residues are poorly structured, whereas residues beyond 10 form a distinct local conformation<xref ref-type="bibr" rid="b17">17</xref><xref ref-type="bibr" rid="b22">22</xref><xref ref-type="bibr" rid="b23">23</xref><xref ref-type="bibr" rid="b24">24</xref><xref ref-type="bibr" rid="b25">25</xref><xref ref-type="bibr" rid="b26">26</xref><xref ref-type="bibr" rid="b27">27</xref><xref ref-type="bibr" rid="b28">28</xref><xref ref-type="bibr" rid="b29">29</xref><xref ref-type="bibr" rid="b30">30</xref>. Structure of the tethered N-terminus of the Alzheimerâs disease amyloid-Î² peptide obtained using X-ray crystallography<xref ref-type="bibr" rid="b31">31</xref> showed that AÎ² region 10â16 is relatively rigid and adopts a mixture of the local polyproline II-helix (PPII) and turn type conformations. The fragment AÎ²<sub>1â16</sub> includes several charged residues with their location typical of ionic self-complementary peptides<xref ref-type="bibr" rid="b32">32</xref>. These residues participate in the formation of electrostatic contacts, which can stabilize both intra and intermolecular interactions. The region 10â16 of AÎ² appeared to be an effective metal ion trapping unit<xref ref-type="bibr" rid="b33">33</xref>. The fragment 6â14 of AÎ² has been determined as the minimal Zn<sup>2+</sup> binding site wherein the ion is coordinated by H6, E11, H13, and H14<xref ref-type="bibr" rid="b34">34</xref>. Under physiological conditions in the presence of Zn<sup>2+</sup> the metal binding domains of several natural AÎ² variants form homo- and hetero-dimeric complexes<xref ref-type="bibr" rid="b35">35</xref><xref ref-type="bibr" rid="b36">36</xref><xref ref-type="bibr" rid="b37">37</xref><xref ref-type="bibr" rid="b38">38</xref>. Residues 11â14 of the two interacting subunits compose the dimer interface wherein two pairs of E11 and H14 residues coordinate a zinc ion<xref ref-type="bibr" rid="b36">36</xref><xref ref-type="bibr" rid="b38">38</xref>.</p>
    <p>Along with the intact AÎ² isoforms which are heterogenous at their N-termini and/or C-termini, the amyloid plaques involve a variety of chemically modified AÎ² variants<xref ref-type="bibr" rid="b39">39</xref>. The AÎ² species extracted from the plaques can initiate pathological aggregation of endogenous AÎ² upon intracerebral injections into animal models of AD<xref ref-type="bibr" rid="b3">3</xref><xref ref-type="bibr" rid="b40">40</xref><xref ref-type="bibr" rid="b41">41</xref>. Several post-translational modifications have been discovered to increase the aggregation rate of AÎ²<xref ref-type="bibr" rid="b42">42</xref>. Some chemical modifications and amino acid changes within the metal binding domain of AÎ² (e.g. isomerization of D7, phosphorylation of S8, and the H6R English familial mutation associated with early onset AD) facilitate zinc-dependent dimerization and/or oligomerization of the domain<xref ref-type="bibr" rid="b36">36</xref><xref ref-type="bibr" rid="b38">38</xref><xref ref-type="bibr" rid="b43">43</xref>, thus suggesting their potential role in initiating the pathological aggregation process. Indeed, peripheral injections of the synthetic AÎ² species bearing isomerized D7 (isoD7-AÎ²) was shown to trigger cerebral amyloidosis <italic>in vivo</italic><xref ref-type="bibr" rid="b44">44</xref>. Little is known about the AÎ² metal binding sites in the aggregated state (oligomers or fibrils), but in general, it seems that the binding sites are similar to those in the monomeric peptide<xref ref-type="bibr" rid="b11">11</xref><xref ref-type="bibr" rid="b45">45</xref>.</p>
    <p>In the current study, we have used high resolution NMR spectroscopy to reveal the structural determinants of zinc-induced AÎ² oligomerization, i.e. the structure elements that are responsible for the ability of AÎ² to form zinc-bound intermolecular complexes. Synthetic peptides corresponding to the metal binding domains of the intact AÎ² (AÎ²<sub>1â16</sub>), of the English H6R AÎ² mutant (H6R-AÎ²<sub>1â16</sub>), AÎ² containing isomerized D7 (isoD7-AÎ²<sub>1â16</sub>) and several truncated and mutant forms of these peptides have been used as experimental models (<xref ref-type="fig" rid="f1">Fig. 1</xref>). Solution structure of the zinc-bridged H6R-AÎ²<sub>1â16</sub> dimer has been determined. This structure provides direct information on the primary zinc-mediated AÎ² dimer interface, formed by the residues <sup>11</sup>EVHH<xref ref-type="bibr" rid="b14">14</xref>. The role of residues H6 and H13 in the emergence of the second Zn<sup>2+</sup>-dependent interface within the interacting metal binding domains AÎ²<sub>1â16</sub> and isoD7-AÎ²<sub>1â16</sub> during their zinc-induced oligomerization has been also revealed. Taken together, the data indicate that interplay of histidine residues in the minimal zinc-binding site 6â14 of AÎ² upon its interactions with zinc ions underlies critical conformational changes of AÎ², which in turn lead to AÎ² dimerization, oligomerization and aggregation. The results provide structural basis for rational design of the AD-modifying drugs aimed at blocking pathological AÎ² aggregation.</p>
    <sec disp-level="1">
      <title>Results</title>
      <sec disp-level="2">
        <title>NMR signal assignments</title>
        <p>Earlier we reported chemical shift assignments of ÐÎ²<sub>1â16</sub><xref ref-type="bibr" rid="b17">17</xref> and H6R-ÐÎ²<sub>1â16</sub><xref ref-type="bibr" rid="b36">36</xref>. <sup>1</sup>H, <sup>13</sup>C and <sup>15</sup>N chemical shifts of the peptides isoD7-ÐÎ²<sub>1â16</sub>, isoD7-ÐÎ²<sub>1â10</sub>, isoD7-H13R-ÐÎ²<sub>1â16</sub>, ÐÎ²<sub>6â16</sub> and their complexes with Zn<sup>2+</sup> ions have been assigned by analysis of the set of 2D homonuclear (NOESY, ROESY, TOCSY, DQF-COSY) and heteronuclear (<sup>13</sup>C-<sup>1</sup>H HSQC and <sup>15</sup>N-<sup>1</sup>H HSQC) NMR experiments. Heteronuclear spectra (<xref ref-type="supplementary-material" rid="S1">Figs S1âS4</xref>) have been acquired at the natural abundance of <sup>13</sup>C and <sup>15</sup>N isotopes. In the case of isoD7-ÐÎ²<sub>1â16</sub>, isoD7-H13R-ÐÎ²<sub>1â16</sub> and ÐÎ²<sub>6â16</sub>
<sup>15</sup>N resonance assignments have been obtained for the free peptides only, as substantial zinc-induced signal broadening does not allow collection of heteronuclear correlation spectra at the natural abundance of <sup>15</sup>N. Resonance assignments for nearly all <sup>1</sup>H and <sup>13</sup>C nuclei have been determined for all studied peptides and their zinc complexes (<xref ref-type="supplementary-material" rid="S1">Tables S1âS7</xref>).</p>
      </sec>
      <sec disp-level="2">
        <title>Structure of the metal binding domains ÐÎ²<sub>1â16</sub>, H6R-ÐÎ²<sub>1â16</sub> and isoD7-ÐÎ²<sub>1â16</sub> in free state in solution</title>
        <p>Structures of the peptides ÐÎ²<sub>1â16</sub>, H6R-ÐÎ²<sub>1â16</sub> and isoD7-ÐÎ²<sub>1â16</sub> in free state in solution is virtually identical, as shown by the NMR spectra of the peptides measured in the absence of zinc ions (<xref ref-type="fig" rid="f2">Fig. 2</xref>, <xref ref-type="supplementary-material" rid="S1">Figs S5</xref> and <xref ref-type="supplementary-material" rid="S1">S6</xref>). Despite the fact that the peptides are relatively flexible, as evidenced by their narrow lines in NMR spectra, several distinct cross peaks detected in NOESY spectra indicate that the dominant backbone conformation in the region of residues 10â15 is close to the left-handed polyproline-II helix, observed in the crystal structure of ÐÎ²<sub>1â16</sub><xref ref-type="bibr" rid="b31">31</xref>. NOEs between amide protons of neighboring residues HN<sup>i</sup>-HN<sup>iâ1</sup> and between amide protons and HÎ± (HN<sup>i</sup>-HÎ±<sup>iâ1</sup>, HN<sup>i</sup>-HÎ±<sup>iâ2</sup>, HN<sup>i</sup>-HÎ±<sup>i+1</sup>, <xref ref-type="supplementary-material" rid="S1">Figs S5</xref> and <xref ref-type="supplementary-material" rid="S1">S6</xref>) confirm such dominant conformation of the fragment 10â15. Proximity of methyl groups of the residue V12 to the side chains of Y10 and H14 (<xref ref-type="fig" rid="f2">Fig. 2</xref>), observed in all three investigated peptides should also be noted. Thus, the fragment 10â15 in all three peptides has the same dominant structure, which can determine zinc-trapping properties of the metal binding domain.</p>
      </sec>
      <sec disp-level="2">
        <title>Aggregation states of H6R-ÐÎ²<sub>1â16</sub>, isoD7-ÐÎ²<sub>1â16</sub> and ÐÎ²<sub>6â16</sub> in the presence of zinc ions</title>
        <p>The peptides behave differently in the presence of Zn<sup>2+</sup>. Addition of equimolar amounts of zinc ions to the peptides isoD7-ÐÎ²<sub>1â16</sub>, ÐÎ²<sub>6â16</sub> and ÐÎ²<sub>1â16</sub> resulted in precipitation of the peptides in contrast to H6R-ÐÎ²<sub>1â16</sub>, which remained in solution in the studied concentration range (up to ~10âmM). These observations show that isoD7-ÐÎ²<sub>1â16</sub>, ÐÎ²<sub>6â16</sub> and ÐÎ²<sub>1â16</sub> undergo zinc-induced oligo- and/or polymerization. The precipitated peptides dissolve in acidic conditions (pH&lt;4), but precipitate again upon the increase of pH above ~6. Such pH dependence indicates involvement of histidine residues in zinc binding. Precipitation of isoD7-ÐÎ²<sub>1â16</sub> has been observed at peptide concentration above ~0.3âmM, ÐÎ²<sub>6â16</sub> above ~0.8âmM and ÐÎ²<sub>1â16</sub> above ~5âmM (<xref ref-type="table" rid="t1">Table 1</xref>). DLS studies evidence the presence of soluble zinc-induced oligomers during precipitation of the peptides (<xref ref-type="table" rid="t1">Table 1</xref>). These data indicate that soluble zinc-induced oligomers precede insoluble aggregates. NMR studies of the interaction of isoD7-ÐÎ²<sub>1â16</sub> and ÐÎ²<sub>6â16</sub> with Zn<sup>2+</sup> ions have been carried out at concentration below ~0.3âmM, where both peptides remain soluble.</p>
        <p>Addition of Zn<sup>2+</sup> ions to all studied peptides leads to substantial line broadening of the NMR signals (<xref ref-type="supplementary-material" rid="S1">Fig. S7</xref>). The nature of the peptide signal broadening primarily is associated with the exchange between multiple conformational states of the complex<xref ref-type="bibr" rid="b46">46</xref><xref ref-type="bibr" rid="b47">47</xref><xref ref-type="bibr" rid="b48">48</xref>. Potentially the aggregation processes can also cause signal broadening. However, the extent of line broadening for peptide H6R-ÐÎ²<sub>1â16</sub> that never aggregated, and the peptides that aggregate is virtually the same. This means that aggregation does not affect NMR line widths of these peptides under the given conditions. Additionally, an extra set of resonances (<xref ref-type="fig" rid="f3">Figs 3</xref> and <xref ref-type="fig" rid="f4">4</xref>, <xref ref-type="supplementary-material" rid="S1">S2</xref> and <xref ref-type="supplementary-material" rid="S1">S3</xref>, <xref ref-type="supplementary-material" rid="S1">S8</xref>) has been found in NMR spectra of the peptides ÐÎ²<sub>1â16</sub>, H6R-ÐÎ²<sub>1â16</sub>, isoD7-ÐÎ²<sub>1â16</sub> and ÐÎ²<sub>6â16</sub> in the presence of zinc ions. This set has been assigned to the dimeric peptide complexes (see below).</p>
      </sec>
      <sec disp-level="2">
        <title>Zinc-induced dimers of ÐÎ²<sub>1â16</sub>, ÐÎ²<sub>6â16</sub>, H6R-ÐÎ²<sub>1â16</sub> and isoD7-ÐÎ²<sub>1â16</sub> have common zinc-mediated dimerization interface</title>
        <p>We previously showed by a combination of NMR, isothermal titration calorimetry (ITC) and surface plasmon resonance methods that a stable dimeric form of the peptide H6R-ÐÎ²<sub>1â16</sub> is formed when bound to a zinc ion<xref ref-type="bibr" rid="b36">36</xref>. Residues E11 and H14 of the two peptide subunits formed the dimerization interface in this complex. For the dimeric form of H6R-ÐÎ²<sub>1â16</sub> a set of characteristic signals was observed in NMR spectra, including marked resonances of the methyl group HÎ³1* of V12 (~0.2 ppm) and amide proton of H14 (~9.5 ppm). The intensity of these signals made it possible to evaluate the dimer ratio, which is dependent on the total peptide concentration and varied between 1â3% for the diluted solutions and 35â40% for the solutions of H6R-ÐÎ²<sub>1â16</sub> at the peptide concentration of 5â8âmM.</p>
        <p>A comparison of the NMR spectra of the peptides ÐÎ²<sub>1â16</sub>, ÐÎ²<sub>6â16</sub>, H6R-ÐÎ²<sub>1â16</sub> and isoD7-ÐÎ²<sub>1â16</sub> in the presence of zinc ions obtained in this study has shown a set of characteristic signals similar to that observed in the work cited above, for all these peptides (<xref ref-type="fig" rid="f3">Fig. 3</xref>, <xref ref-type="supplementary-material" rid="S1">S3, S8</xref>). At low concentration of the peptides ÐÎ²<sub>1â16</sub>, H6R-ÐÎ²<sub>1â16</sub> and isoD7-ÐÎ²<sub>1â16</sub> (~0.2 mM) fraction of the dimeric form is nearly identical (<xref ref-type="fig" rid="f3">Fig. 3</xref>). Fraction of the dimeric forms rises with concentration of the peptides as expected for any dimerization process. Such tendency has been shown for H6R-ÐÎ²<sub>1â16</sub><xref ref-type="bibr" rid="b36">36</xref>, which has the highest dimer abundance among the studied peptides. The common set of characteristic signals found for the dimers of ÐÎ²<sub>1â16</sub>, ÐÎ²<sub>6â16</sub>, H6R-ÐÎ²<sub>1â16</sub> and isoD7-ÐÎ²<sub>1â16</sub> indicates that all the dimers have the same zinc-induced dimerization interface, namely, <sub>11</sub>EVHH<sub>14</sub>.</p>
      </sec>
      <sec disp-level="2">
        <title>Equilibrium between zinc-bound monomers and dimers of ÐÎ²<sub>1â16</sub> isoforms</title>
        <p>Equilibrium between free peptide and its zinc-bound monomer complex is fast on the NMR time scale. In contrast, equilibrium between zinc-bound monomers and dimers is slow on the NMR time scale, as evidenced by the two separate sets of NMR signals (<xref ref-type="fig" rid="f3">Fig. 3</xref>, <xref ref-type="fig" rid="f4">4</xref>, <xref ref-type="supplementary-material" rid="S1">S2,S3,S8</xref>). The exchange between monomers and dimers is unambiguously confirmed by the rotating frame nuclear Overhauser effect spectroscopy (ROESY) since cross-peaks originating from the through-space dipole-dipole interaction (NOE) have opposite signs to the cross-peaks derived from chemical exchange. <xref ref-type="fig" rid="f4">Figure 4</xref> illustrates NOEs between S8 HÎ± and HÎ² protons (negative, blue), and exchange cross peaks between several HÎ± signals of monomeric and dimeric forms (red, positive). Exchange between zinc-bound monomers and dimers of H6R-ÐÎ²<sub>1â16</sub> and isoD7-ÐÎ²<sub>1â16</sub> is also confirmed by characteristic cross-peaks in the NOESY spectra (<xref ref-type="supplementary-material" rid="S1">Fig. S8</xref>) demonstrating exchange between V12 HÎ³1* signals. Both peptides show identical patterns of NMR signals and differ only by fraction of the dimeric forms.</p>
        <p>Rate constants <italic>k</italic><sub><italic>m</italic></sub>â<sub><italic>â</italic></sub>â<sub><italic>d</italic></sub> and <italic>k</italic><sub><italic>d</italic></sub>â<sub><italic>â</italic></sub>â<sub><italic>m</italic></sub> at equilibrium between the monomeric and dimeric complexes of H6R-ÐÎ²<sub>1â16</sub> with Zn<sup>2+</sup> have been measured using the magnetization transfer NMR experiments (see <xref ref-type="supplementary-material" rid="S1">Supporting information</xref> pp. S24-S28 for details). It has been found that an effective rate constant <italic>k</italic><sub><italic>mâd</italic></sub> measured at the total peptide concentration of 2.3âmM in the presence of half molar equivalence of ZnCl<sub>2</sub> equals to 8.6âÂ±â0.6âs<sup>â1</sup> and <italic>k</italic><sub><italic>dâm</italic></sub> equals to 31.3âÂ±â2.3âs<sup>â1</sup>.</p>
      </sec>
      <sec disp-level="2">
        <title>Structure of zinc-mediated H6R-ÐÎ²<sub>1â16</sub> dimer in solution</title>
        <p>Significant ratio of stable (on NMR time scale) zinc-bound H6R-ÐÎ²<sub>1â16</sub> dimers allowed to determine the dimer structure in solution. The NMR structure has been determined using the set of distance restraints collected from 2D NOESY and ROESY spectra and a set of constraints between zinc ion and residues E11 and H14 (<xref ref-type="table" rid="t2">Table 2</xref>). In addition to NOEs between the signals of the dimer, NOEs between the signals of zinc-bound monomer have been also included in the list of distance restraints used for structure calculation (<xref ref-type="table" rid="t2">Table 2</xref>). Due to the equilibrium between zinc-bound monomer and dimer, more intensive signals of monomer (<xref ref-type="fig" rid="f5">Fig. 5</xref>) contain all the information about interatomic distances within the dimer via the transferred NOE mechanism. Similar transferred NOE mechanism is observed in the equilibrium between free peptide and its complex with a larger protein<xref ref-type="bibr" rid="b49">49</xref>. Effectiveness of such mechanism is determined by the substantially more effective cross-relaxation in dimer due to its slower molecular tumbling.</p>
        <p>QM/MM calculations have been carried out to determine the restraints that describe geometry of the zinc-mediated interface formed by pairs of E11 and H14 from the interacting subunits. An approach similar to that described earlier for the determination of NMR structure of rat ÐÎ²<sub>1â16</sub> complex with zinc ions<xref ref-type="bibr" rid="b47">47</xref> has been used in the calculations. Tetrahedral geometry of the zinc ion coordination sphere originated from quantum mechanics calculations (<xref ref-type="supplementary-material" rid="S1">Fig. S12B</xref>). Such geometry is in good agreement with the principles governing Zn binding in proteins<xref ref-type="bibr" rid="b50">50</xref> and in agreement with the previously determined structures of ÐÎ²<sub>1â16</sub> zinc-bound complexes<xref ref-type="bibr" rid="b11">11</xref><xref ref-type="bibr" rid="b17">17</xref><xref ref-type="bibr" rid="b34">34</xref><xref ref-type="bibr" rid="b47">47</xref>.</p>
        <p>Single set of zinc-bound dimer chemical shifts indicates that dimer subunits are chemically equivalent. Therefore, each NOE has been assumed to represent either intra-chain correlation or correlation between two adjacent subunits. All NOEs have been treated in the structure calculations as ambiguous distance restraints allowing optimization protocol to find optimal assignments.</p>
        <p>A family of 20 NMR structures has been determined on the basis of 181 experimental restraints (see <xref ref-type="table" rid="t1">Table 1</xref> for details) using simulated annealing MD protocol in explicit water environment<xref ref-type="bibr" rid="b51">51</xref>. For most of the residues, the number of NOEs per residue is between 15 and 40 (<xref ref-type="supplementary-material" rid="S1">Fig. S9</xref>). Statistics of the final ensemble are given in <xref ref-type="table" rid="t1">Table 1</xref> and superposition of the final family of calculated structures is presented in <xref ref-type="supplementary-material" rid="S1">Fig. S10</xref>. A representative structure was selected from the ensemble of calculated structures as being the one that is closest to all the other structures and thus gives the lowest sum of pairwise RMSD for the remainder of the structures in the family. RMSD between the family of calculated structures and the representative structure is about 2.3âÃ for the backbone heavy atoms. RMSD between the structures in the final family for heavy atoms of the dimerization interface core (residues 8â15) is about 1.0âÃ (<xref ref-type="table" rid="t1">Table 1</xref>). On Ramachandran plot (<xref ref-type="supplementary-material" rid="S1">Fig. S11</xref>), 73.5% of the residues in the whole NMR family are in the most favored regions and none in the disallowed regions. Representative structure has been additionally optimized using the QM/MM method in order to refine the geometry of Zn<sup>2+</sup> environment (<xref ref-type="fig" rid="f6">Figs 6</xref> and <xref ref-type="supplementary-material" rid="S1">S12</xref>).</p>
      </sec>
      <sec disp-level="2">
        <title>Identification of the second zinc-dependent dimerization interface within ÐÎ²<sub>1â16</sub>, ÐÎ²<sub>6â16</sub> and isoD7-ÐÎ²<sub>1â16</sub></title>
        <p>Peptides H6R-ÐÎ²<sub>1â16</sub>, ÐÎ²<sub>1â16</sub>, isoD7-ÐÎ²<sub>1â16</sub> and ÐÎ²<sub>6â16</sub> have identical primary zinc-mediated homodimerization interface, which shows characteristic resonances, such as HÎ³1* of V12 (<xref ref-type="fig" rid="f3">Figs 3</xref> and <xref ref-type="supplementary-material" rid="S1">S3, S8</xref>). In the interface, pairs of residues E11 and H14 of the interacting subunits coordinate a common zinc ion. In the presence of equimolar amounts of zinc ions only H6R-ÐÎ²<sub>1â16</sub> does not precipitate up to 10âmM, whereas the other peptides rapidly precipitate when their concentration reaches threshold values (&gt;5âmM for ÐÎ²<sub>1â16</sub>, &gt;0.2âmM for isoD7-ÐÎ²<sub>1â16</sub>, &gt;0.8âmM for ÐÎ²<sub>6â16</sub>) (<xref ref-type="table" rid="t1">Table 1</xref>). Apparently, precipitation can occur only if an oligomer subunit possesses at least two sites that sterically can be involved in the formation of zinc-mediated interfaces with other peptide subunits. Accordingly, the ÐÎ²<sub>1â16</sub>, ÐÎ²<sub>6â16</sub> and isoD7-ÐÎ²<sub>1â16</sub> peptides must have a second dimerization interface located within the ÐÎ² minimal zinc binding site 6â14<xref ref-type="bibr" rid="b34">34</xref>. The fact that aggregation of H6R-ÐÎ²<sub>1â16</sub> is not observed at any peptide concentration as shown in <xref ref-type="table" rid="t1">Table 1</xref>, clearly indicates the involvement of residue H6 in the second zinc-dependent interface. Considering that side chains of residues Asp, Glu Ð¸ His are typical zinc chelators and E11 Ð¸ H14 are part of the primary dimerization interface, one can rationally assume that the second dimerization interface should include residues D7 (isoD7) or H13 in addition to H6.</p>
        <p>To probe involvement of isoD7 in the second dimerization interface we have studied a capacity of the model peptide isoD7-ÐÎ²<sub>1â10</sub> to form dimers in the presence of zinc ions. We have performed NMR titration experiments using the method of continuous variations<xref ref-type="bibr" rid="b36">36</xref><xref ref-type="bibr" rid="b38">38</xref><xref ref-type="bibr" rid="b52">52</xref>. The results show that stoichiometry of interaction of isoD7-ÐÎ²<sub>1â10</sub> with Zn<sup>2+</sup> is 1:1 (<xref ref-type="supplementary-material" rid="S1">Fig. S13B</xref>, <xref ref-type="table" rid="t1">Table 1</xref>). The coordination centers of zinc ion in the monomeric complex with isoD7-ÐÎ²<sub>1â10</sub> have been identified from changes of the chemical shifts between free and zinc-bound states (<xref ref-type="supplementary-material" rid="S1">Fig. S14</xref>, <xref ref-type="supplementary-material" rid="S1">Tables S5, S6</xref>). In addition to imidazole ring of H6, Zn<sup>2+</sup> is coordinated by the side chain carboxyl group of isoD7 and two backbone carbonyl groups of the residues F4 and H6. Chemical shift changes data (<xref ref-type="supplementary-material" rid="S1">Fig. S15</xref>) allowed to calculate the binding constant of Zn<sup>2+</sup> to isoD7-ÐÎ²<sub>1â10</sub>, K<sub>a</sub>â=â1.19âÂ±â0.06Â·10<sup>3</sup>âM<sup>â1</sup> (<xref ref-type="supplementary-material" rid="S1">Fig. S13A</xref>, <xref ref-type="table" rid="t1">Table 1</xref>). The data show that the peptide forms a monomeric complex with zinc ion and thus isoD7 is not involved in the second dimerization interface.</p>
        <p>Similarly, to probe involvement of residue H13 in the second dimerization interface we have studied the model peptide isoD7-H13R-ÐÎ²<sub>1â16</sub>. The H13R substitution has been designed to minimize changes in the peptide properties relative to isoD7-ÐÎ²<sub>1â16</sub>. Chemical shifts of the peptide in the presence and absence of zinc ions are given in <xref ref-type="supplementary-material" rid="S1">Supplementary material (Tables S3 and S4)</xref>. NMR studies of the interaction of isoD7-H13R-ÐÎ²<sub>1â16</sub> with Zn<sup>2+</sup> (<xref ref-type="supplementary-material" rid="S1">Fig. S16</xref>) have shown zinc binding constant K<sub>a</sub>â=â1.35âÂ±â0.06Â·10<sup>3</sup>âM<sup>â1</sup> (<xref ref-type="supplementary-material" rid="S1">Fig. S17A</xref>, <xref ref-type="table" rid="t1">Table 1</xref>) and stoichiometry (1:1) (<xref ref-type="supplementary-material" rid="S1">Fig. S17B</xref>, <xref ref-type="table" rid="t1">Table 1</xref>). Zinc-induced chemical shift changes (<xref ref-type="supplementary-material" rid="S1">Fig. S18</xref>) indicate that side chains of the two histidine residues (H6 and H14) are involved in the coordination of Zn<sup>2+</sup>. Chemical shifts of E11 do not change upon interaction of the peptide with Zn<sup>2+</sup>, suggesting that this residue is not involved in its coordination. RMSD of the <sup>1</sup>H and <sup>13</sup>C chemical shifts between the free and zinc-bound peptides (<xref ref-type="supplementary-material" rid="S1">Fig. S18</xref>) indicate that zinc ion is coordinated by backbone carbonyl groups of the residues H6 and R5, similarly to that observed earlier in the S8 phophorylated AÎ²<sub>1â16</sub> peptide<xref ref-type="bibr" rid="b38">38</xref>.</p>
        <p>Taken together, the described data show that in zinc-induced oligomers of the ÐÎ²<sub>1â16</sub>, ÐÎ²<sub>6â16</sub> and isoD7-ÐÎ²<sub>1â16</sub> peptides each subunit interacts with the adjacent subunits via residues E11 and H14 from the primary dimerization interface, and residues H6 and H13 from the second one.</p>
      </sec>
      <sec disp-level="2">
        <title>The origins of higher oligomerization propensity of isoD7-ÐÎ²<sub>1â16</sub> and ÐÎ²<sub>6â16</sub> compared to ÐÎ²<sub>1â16</sub></title>
        <p>Our experimental results indicate that isomerization of D7 as well as truncation of the first five residues facilitate formation of the second Zn-dependent interaction site. To understand why a relatively small change of the peptide structure between ÐÎ²<sub>1â16</sub> and isoD7-ÐÎ²<sub>1â16</sub> causes dramatic change in their zinc-induced oligomerization, MD simulations have been performed for homodimer AÎ²<sub>1â16</sub>Â·AÎ²<sub>1â16</sub> and heterodimer AÎ²<sub>1â16</sub>Â·isoD7-AÎ²<sub>1â16</sub>. Conformational behavior of AÎ²<sub>1â16</sub> and isoD7-AÎ²<sub>1â16</sub> chains in the respective homodimer and heterodimer, has been examined in MD trajectories. In the MD simulations the primary zinc-dependent interface structure has been kept in its initial conformation, and distances between the imidazole rings of residues H6 and H13 in the second interface in both AÎ²<sub>1â16</sub> and isoD7-AÎ²<sub>1â16</sub> chains have been constrained in order to keep them close enough for zinc ion coordination.</p>
        <p>MD simulations have shown that residues D7 and S8 in the AÎ²<sub>1â16</sub> chain form a stable bend (RMSD over N, C and CÎ± atoms of residues 7 and 8 was 0.13âÃ). Such bend is stabilized by hydrogen bond between the D7 side-chain carboxyl and S8 side-chain hydroxyl (<xref ref-type="fig" rid="f7">Fig. 7a</xref>). In contrast, in the isoD7-AÎ²<sub>1â16</sub> chain residues D7 and S8 do not form a bend, but demonstrate a propensity to form extended conformation (<xref ref-type="fig" rid="f7">Fig. 7b</xref>). Thus, structural changes associated with the isomerization of D7 (elongation of the peptide backbone by one additional CH<sub>2</sub> group and reduction of the side-chain) lead to disruption of the interaction between residues D7 and S8.</p>
        <p>MD results show that in both peptides ÐÎ²<sub>1â16</sub> and isoD7-ÐÎ²<sub>1â16</sub>, residues H6 and H13 adopt a conformation supporting interaction with Zn<sup>2+</sup>. However, probability to adopt the most favorable conformation is higher for the isoD7-ÐÎ²<sub>1â16</sub> peptide. On the contrary, such conformational space in ÐÎ²<sub>1â16</sub> peptide is restricted due to the bent region 7â8 (<xref ref-type="supplementary-material" rid="S1">Fig. S19</xref>). Thus, isomerization of D7 increases capacity of the residues H6 and H13 to form the second zinc-dependent interface interaction with zinc ion, which facilitates oligomerization of the peptide. Truncation of the first five residues of ÐÎ²<sub>1â16</sub> forms the ÐÎ²<sub>6â16</sub> peptide with increased conformational freedom of the N-terminal residue H6 and similarly facilitates zinc-induced oligomerization.</p>
      </sec>
    </sec>
    <sec disp-level="1">
      <title>Discussion</title>
      <p>In human tissues, AÎ² is a group of peptides, heterogenous at their N-termini and/or C-termini and produced by the Î²- and Î³-secretase-dependent cleavage of amyloid precursor protein<xref ref-type="bibr" rid="b53">53</xref>. Structural characterization of the full lenght AÎ² monomer in solution is difficult due to the tendency of the peptide to aggregate. It was found that the soluble AÎ²<sub>1â42</sub> peptide is an intrinsically disordered polypeptide in aqueous solution, having Î²-strand secondary structure within the segments 2â7, 16â23, 28â32, and 34â36<xref ref-type="bibr" rid="b54">54</xref>. Solid-state NMR spectroscopy and electron microscopy allowed to identify diverse morphologies and structures in AÎ² fibrils (reviewed in<xref ref-type="bibr" rid="b55">55</xref><xref ref-type="bibr" rid="b56">56</xref>). The metal-binding domain 1â16 was found to be flexible, situated outside of the hydrophobic core formed by the residues 17â42<xref ref-type="bibr" rid="b20">20</xref><xref ref-type="bibr" rid="b57">57</xref>. It is worth noting that the absence of this domain in the so called p3 peptide, which comprises the AÎ² region 17â42, prevents the formation of oligomers<xref ref-type="bibr" rid="b57">57</xref><xref ref-type="bibr" rid="b58">58</xref>. Another fact that three amino acid substitutions that discern AÎ² of rats and mice from all other mammals and protect rodents against AD are situated within the metal binding domain, indicating its involvement in initialization of the pathological AÎ² aggregation. Several AD-causing mutations are also located in the metal binding domain of AÎ²<xref ref-type="bibr" rid="b59">59</xref><xref ref-type="bibr" rid="b60">60</xref>. A role of AÎ²<sub>1â16</sub> in the AD pathology is that it is required for the formation of zinc-induced oligomers. Antibodies targeting the N-terminal region of AÎ² are able to block the formation of AÎ²40 amyloids<xref ref-type="bibr" rid="b61">61</xref>, thus suggesting that the N-terminal domain contributes to the formation and/or the maturation of AÎ² fibrils.</p>
      <p>Our results indicate that conformation of the 10â15 region of the metal binding domain in absence of zinc ions is identical in all studied variants of AÎ²<sub>1â16</sub>, and that it is likely to be pre-formed for an effective zinc ion trapping. The region 11â14 was shown to play a principle role in Zn<sup>2+</sup> binding in the monomeric complex<xref ref-type="bibr" rid="b17">17</xref><xref ref-type="bibr" rid="b34">34</xref>. Such interaction includes two consecutive steps, (i) primary zinc ion binding by side chains of the residues E11, H13, H14 and a water molecule, (ii) substitution of water by the residue H6 due to movement of the fragments 1â8 and 11â14 towards each other.</p>
      <p>It was suggested that a zinc ion binds to monomeric AÎ² and then the zinc-peptide complex undergoes conformational changes that lead to the formation in the formation of zinc-induced AÎ² oligomers<xref ref-type="bibr" rid="b11">11</xref><xref ref-type="bibr" rid="b21">21</xref><xref ref-type="bibr" rid="b62">62</xref><xref ref-type="bibr" rid="b63">63</xref>. The role of <sub>11</sub>EVHH<sub>14</sub> fragment in the formation of AÎ² dimers was reported previously<xref ref-type="bibr" rid="b11">11</xref><xref ref-type="bibr" rid="b36">36</xref><xref ref-type="bibr" rid="b37">37</xref><xref ref-type="bibr" rid="b38">38</xref><xref ref-type="bibr" rid="b64">64</xref>. In the current study we have established the three-dimensional structure of a zinc-linked dimer of H6R-ÐÎ²<sub>1â16</sub>, with the dimerization interface formed by the side chains of residues E11 and H14. Residues 10â15 also contribute to structure stabilization by hydrophobic interactions between Y10 and V12, and by forming hydrogen bonds between the HN protons of H14 and Gln15 and the backbone carbonyl groups of E11 and V12 respectively (<xref ref-type="fig" rid="f6">Fig. 6</xref>, <xref ref-type="supplementary-material" rid="S1">Fig. S12</xref>). Low field shifts of these two amide protons are in agreement with this conclusion. Characteristic high field shift of the resonance of HÎ³1*of V12 originates from its proximity to the aromatic ring of Y10 in the hydrophobic core and additionally validates the structure. Thus, binding of a zinc ion to the <sub>11</sub>EVHH<sub>14</sub> fragment leads to formation of the peptide dimer where one zinc ion is coordinated by the residues E11 and H14 from the two interacting peptide chains.</p>
      <p>Miller <italic>et al.</italic><xref ref-type="bibr" rid="b62">62</xref> discuss two possible scenarios of the zinc-induced amyloidogenesis. In the first one, metal ions bind amyloid monomers and induce their assembly into oligomers via interactions of the zinc-bound complexes. Alternative mechanism presumes that metal ions bind to pre-formed apo-oligomers of AÎ². Lim <italic>et al.</italic><xref ref-type="bibr" rid="b13">13</xref> showed that zinc binding to AÎ² initiates a cascade of conformational changes leading to intermolecular interactions of AÎ² via residues 12â21. After an initial structure rearrangement caused by zinc binding, the C-terminal residues readjust their conformation to support effective intermolecular interaction<xref ref-type="bibr" rid="b18">18</xref><xref ref-type="bibr" rid="b21">21</xref><xref ref-type="bibr" rid="b47">47</xref><xref ref-type="bibr" rid="b57">57</xref><xref ref-type="bibr" rid="b58">58</xref><xref ref-type="bibr" rid="b59">59</xref><xref ref-type="bibr" rid="b61">61</xref><xref ref-type="bibr" rid="b65">65</xref>. Similar structural changes of the metal-free AÎ²<sub>1â40</sub> peptides were also observed in the presence of the preformed oligomers<xref ref-type="bibr" rid="b13">13</xref>, suggesting that such conformational transitions may constitute a general molecular mechanism of the AÎ² amyloidogenesis.</p>
      <p>We have shown here for AÎ²<sub>1â16</sub> and isoD7-AÎ²<sub>1â16</sub> that formation of the primary zinc-dependent dimerization interface by residues E11 and H14 initiates conformational rearrangement leading to formation of the second dimerization interface by residues H6 and H13 (<xref ref-type="fig" rid="f7">Fig. 7</xref>). Emergence of this second interface is a key event enabling zinc-induced oligomerization of the metal binding domain (<xref ref-type="fig" rid="f8">Fig. 8</xref>).</p>
      <p>If a zinc-induced dimer is formed by native AÎ²<sub>1â16</sub> via primary interface, it restricts conformational mobility of the peptide. We hypothesize that this can result in disruption of the reciprocal aligning of residues 6 and 13 necessary to form the second interface, leading to lower fraction of peptides with both interfaces (<xref ref-type="supplementary-material" rid="S1">Fig. S19</xref>). This explains moderate susceptibility of the native peptide AÎ²<sub>1â16</sub> to oligomerization (AÎ²<sub>1â16</sub> precipitates at concentrations &gt;5âmM, <xref ref-type="table" rid="t1">Table 1</xref>). In comparison with AÎ²<sub>1â16</sub>, isoD7-AÎ²<sub>1â16</sub> undergoes oligomerization at substantially higher rate (isoD7-AÎ²<sub>1â16</sub> precipitates at concentrations &gt;0.3âmM). Isomerization of D7 considerably increases conformational space of the peptide backbone and facilitates favorable aligning of the side chains of residues H6 and H13 that form the second dimerization interface. Another way to increase conformational freedom of the H6 side chain is to remove the first five residues of AÎ², including residues E1 and D3 capable of electrostatically interacting with H6<xref ref-type="bibr" rid="b34">34</xref>. Indeed, peptide AÎ²<sub>6â16</sub> precipitates at ~0.8âmM (<xref ref-type="table" rid="t1">Table 1</xref>). Notably, enzymatic removal of the first five AÎ² residues is performed by ACE<xref ref-type="bibr" rid="b66">66</xref> as we showed earlier, which can potentially link ACE to Alzheimerâs disease.</p>
      <p>The results obtained in this study allow to propose the molecular mechanism of zinc-dependent oligomerization of AÎ² metal binding domain (<xref ref-type="fig" rid="f8">Fig. 8</xref>). Oligomerization starts with formation of zinc-peptide monomeric complex (<xref ref-type="fig" rid="f8">Fig. 8b</xref>), and subsequent transformation of the complex to a dimer (<xref ref-type="fig" rid="f8">Fig. 8c</xref>), where zinc ion is coordinated by the side chains of residues E11 and H14 from the interacting peptide molecules. After this, conformational rearrangement in the segments 6â14 of each subunit leads to formation of the second zinc-dependent dimerization interface composed of residues H6 and H13. The dimer becomes a seed of subsequent zinc-dependent oligomerization leading to formation of higher order soluble oligomers that are transformed into insoluble aggregates (<xref ref-type="fig" rid="f8">Fig. 8d</xref>). In contrast with the earlier concepts of polymorphism of AÎ² within zinc-dependent oligomers, our data suggest that the AÎ² metal binding domain has a distinct three-dimensional structure, allowing the domain to simultaneously interact with two other AÎ² molecules. This could trigger a âchain reactionâ of zinc-induced AÎ² oligomerization. This mechanism is in line with our recent <italic>in vivo</italic> studies showing that synthetic peptides specifically binding the AÎ² <sub>11</sub>EVHH<sub>14</sub> region and preventing zinc-induced AÎ² dimerization, significantly reduce progression of cerebral amyloidosis in transgenic mice<xref ref-type="bibr" rid="b67">67</xref>.</p>
    </sec>
    <sec disp-level="1">
      <title>Conclusions</title>
      <p>We have demonstrated that in the AÎ² metal binding domains of intact, H6R mutant and the isoD7 AÎ² isoforms in the absence and presence of zinc ions, the dominant backbone conformation of the fragment 10â15 is identical. This fragment forms primary zinc-mediated dimerization interface of all studied metal binding domains. Solution structure of zinc-mediated H6R-ÐÎ²<sub>1â16</sub> dimer has been determined, providing insight into the mechanism of formation of the dimerization interface. Zinc-induced oligomerization of synthetic peptides representing the 1â16 metal binding domains of natural ÐÎ² variants has been shown to follow the same molecular mechanism: (i) peptide dimer is formed through the primary zinc-mediated interface <sub>11</sub>EVHH<sub>14</sub>; (ii) residues H6 and H13 are realigned creating the second zinc-dependent interface in each subunit; (iii) the dimer becomes a seed of subsequent zinc-dependent oligomerization of AÎ²<sub>1â16</sub>. Our results indicate that the extent of conformational freedom of residue H6 determines the propensity of AÎ²<sub>1â16</sub> isoforms to undergo zinc-induced oligomerization. Targeting of AÎ² zinc-mediated interfaces may provide a therapeutic route for AD treatment.</p>
    </sec>
    <sec disp-level="1">
      <title>Methods</title>
      <sec disp-level="2">
        <title>Materials</title>
        <p>All chemicals and solvents were of HPLC-grade or better and were obtained from Sigma-Aldrich (St. Louis, MO, USA). Synthetic peptides (purity &gt; 98% checked by RP-HPLC) ÐÎ²<sub>1â16</sub> (DAEFRHDSGYEVHHQK), ÐÎ²<sub>6â16</sub> (HDSGYEVHHQK), H6R-ÐÎ²<sub>1â16</sub> (DAEFRRDSGYEVHHQK), isoD7-ÐÎ²<sub>1â16</sub> (DAEFRH[isoD]SGYEVHHQK, where [isoD] - isoaspartate), isoD7-H13R-ÐÎ²<sub>1â16</sub> (DAEFRH[isoD]SGYEVRHQK, and isoD7-ÐÎ²<sub>1â10</sub> (DAEFRH[isoD]SGY) were purchased from Biopeptide Co., LLC (San Diego, CA, USA). C-termini of all the peptides were protected with amide group. N-termini of ÐÎ²<sub>1â16</sub> and H6R-ÐÎ²<sub>1â16</sub> were either unprotected or protected with acetyl. N-terminus of ÐÎ²<sub>6â16</sub>, isoD7-ÐÎ²<sub>1â16</sub>, isoD7-H13R-ÐÎ²<sub>1â16</sub> and isoD7-ÐÎ²<sub>1â10</sub> were protected with acetyl group. The lyophilized peptides were dissolved in buffer before each experiment. Concentration of the peptides was determined by UV absorption spectroscopy using spectrophotometer Cary50 (Varian) and the extinction coefficient of 1280 M<sup>â1</sup>âcm<sup>â1</sup> at 280ânm (from Tyr 10 of AÎ²). Zinc chloride (99.99%, ACROS Organics) prior to the weighing was dried out during 1â2âhours at 150âÂ°C.</p>
      </sec>
      <sec disp-level="2">
        <title>Dynamic light scattering</title>
        <p>Dynamic light scattering (DLS) measurements were carried out on a Zetasizer Nano ZS apparatus (Malvern Instruments Ltd., UK) in accordance with the manufacturer instruction. The 120-Î¼L aliquots of peptide solutions were placed into a BRAND UV microcuvetter (BRAND GMBH, Germany) and used for the measurements. Measurements of peptides in the presence of Zn<sup>2+</sup> were carried out within 10âminutes after addition of two-fold molar excess of ZnCl<sub>2</sub> to the peptide solutions. The instrument is equipped with a He-Ne laser source (Î»=632.8ânm) and operates in the back-scatting mode, measuring particle size in the range between 0.6ânm and 10âÎ¼m. Particle size distribution was estimated using a CONTIN data analysis utility with spherical approximation of the particles, available as a part of the instrument software.</p>
      </sec>
      <sec disp-level="2">
        <title>Turbidity measurements</title>
        <p>Measurements were performed on a NanoDrop 1000 spectrophotometer (Thermo Scientific, USA). The optical density of peptide solutions was measured at 350ânm and 405ânm, using 2âÎ¼L aliquots of the peptide solutions. Measurements of peptides in the presence of Zn<sup>2+</sup> were carried out after 30â40âminutes following addition of ZnCl<sub>2</sub> to the peptide solutions.s.</p>
      </sec>
      <sec disp-level="2">
        <title>Isothermal titration calorimetry (ITC)</title>
        <p>The thermodynamic parameters of zinc binding to AÎ²<sub>6â16</sub> were measured using a MicroCal iTC200 System (GE Healthcare Life Sciences, USA) as described previously<xref ref-type="bibr" rid="b36">36</xref><xref ref-type="bibr" rid="b43">43</xref><xref ref-type="bibr" rid="b47">47</xref>. Experiments were carried out at 25âÂ°C in 50âmM Tris buffer, pH 7.3. 2âÎ¼L aliquots of the ZnCl<sub>2</sub> solution were injected into the 0.2âmL cell containing the peptide solution to obtain a complete binding isotherm. The titration curves were fitted using MicroCal Origin software. Association constant (K<sub>a</sub>), binding stoichiometry and enthalpy were determined by a non-linear regression fitting procedure (<xref ref-type="supplementary-material" rid="S1">Fig. S20</xref>).</p>
      </sec>
      <sec disp-level="2">
        <title>NMR experiments</title>
        <p>Peptides in the concentration of 0.2â2âmM were dissolved in 10â20âmM bis-Tris-d<sub>19</sub> (2,2-Bis(hydroxymethyl)-2,2â²,2â³-nitrilotriethanol-d<sub>19</sub> with 98% <sup>2</sup>D enrichment) buffer solution (pH 6.8). Sodium salt of 3-(trimethylsilyl)propionic-2,2,3,3-d<sub>4</sub> acid in the concentration of 10â40âÎ¼M was added as a standard. NMR spectra were measured in the temperature range between 274âK and 308âK either in D<sub>2</sub>O or in 90% H<sub>2</sub>O/10% D<sub>2</sub>O on a Bruker AVANCE 600âMHz spectrometer equipped with a triple resonance (<sup>1</sup>H, <sup>13</sup>C and <sup>15</sup>N) pulsed field z gradient probe or on a Varian INOVA 600âMHz spectrometer equipped with a triple resonance (<sup>1</sup>H, <sup>13</sup>C and <sup>15</sup>N) cryoprobe. 1D NMR spectra were processed and analyzed using the Mnova software (Mestrelab Research, Spain). 2D NMR spectra were processed by NMRPipe<xref ref-type="bibr" rid="b68">68</xref> and analyzed using SPARKY<xref ref-type="bibr" rid="b69">69</xref>.</p>
      </sec>
      <sec disp-level="2">
        <title>NMR signal assignment</title>
        <p>The <sup>1</sup>H, <sup>15</sup>N and <sup>13</sup>C signal assignments of isoD7-ÐÎ²<sub>1â10</sub>, isoD7-ÐÎ²<sub>1â16</sub>, isoD7-H13R-ÐÎ²<sub>1â16</sub> and ÐÎ²<sub>6â16</sub> peptides in free form and in complex with zinc ions were obtained using the following 2D spectra: DQF-COSY, TOCSY (mixing time of 70 and 80âms), NOESY (mixing time of 200, 225, 250 and 300âms), <sup>13</sup>C-<sup>1</sup>H HSQC and <sup>15</sup>N-<sup>1</sup>H HSQC. Heteronuclear experiments were measured at the natural abundance of the <sup>13</sup>C and <sup>15</sup>N isotopes (<xref ref-type="supplementary-material" rid="S1">Fig. S1âS4</xref>). Chemical shifts are presented in the <xref ref-type="supplementary-material" rid="S1">supporting material (Tables S1âS7)</xref>.</p>
      </sec>
      <sec disp-level="2">
        <title>NMR titration experiments</title>
        <p>To identify the amino acid residues that coordinate zinc ion in the peptides isoD7-ÐÎ²<sub>1â10</sub> and isoD7-H13R-ÐÎ²<sub>1â16</sub>, and for determining association constants of zinc ions NMR titration experiments were carried out. Peptides at concentration of 1.0â1.5âmM at pH 6.8â7.0 were titrated with a solution of ZnCl<sub>2</sub> in a buffer of identical composition at the same pH value. 1D spectra were recorded for each titration point. <xref ref-type="supplementary-material" rid="S1">Figures S15</xref> and <xref ref-type="supplementary-material" rid="S1">S16</xref> show changes of the chemical shifts with increasing molar content of [Zn<sup>2+</sup>] from 0.05 to 10.0 relatively to the peptide concentration. The volume of solution at the final point increased from 600 to 800âÎ¼L. Chemical shift changes of the representative signals in titration experiments were used for calculation of the K<sub>a</sub> values (<xref ref-type="supplementary-material" rid="S1">Figs S13A</xref> and <xref ref-type="supplementary-material" rid="S1">S17A</xref>). The linear nature of ÎÎ´ values ÎÎ´ presented in Scatchard coordinates<xref ref-type="bibr" rid="b52">52</xref> confirms equilibrium between the free and zinc-bound peptide forms.</p>
        <p>Method of continuous variations<xref ref-type="bibr" rid="b52">52</xref> was used to determine stoichiometry of zinc binding to the peptides isoD7-ÐÎ²<sub>1â10</sub> and isoD7-H13R-ÐÎ²<sub>1â16</sub>. This involved preparation of a series of samples containing both the peptide and ZnCl<sub>2</sub> in varying proportions of the components, but in a fixed total concentration (from 1.0 to 1.7âmM). Changes of the chemical shifts induced by the interaction of the peptide with zinc ions were analyzed. The plots of the product ÎÎ´Â·[P]<sub>0</sub> (ÎÎ´ â change of the chemical shift; [P]<sub>0</sub> â total peptide concentration in the sample) versus the mole fraction of [Zn<sup>2+</sup>] show maximum at the fraction value, which corresponds to the stoichiometry (<xref ref-type="supplementary-material" rid="S1">Figs S13B</xref> and <xref ref-type="supplementary-material" rid="S1">S17B</xref>).</p>
      </sec>
      <sec disp-level="2">
        <title>Magnetization transfer experiments</title>
        <p>In order to measure exchange rates between monomeric and dimeric states of the ZnÂ·H6R-ÐÎ²<sub>1â16</sub> complex, magnetization transfer NMR technique was used. Magnetization transfer experiments involved selective excitation of the signal at 0.9 ppm, which belongs to the methyl group HÎ³1* of V12 in the monomeric form of zinc-peptide complex, with subsequent detection of the intensity of the signal at 0.2 ppm, which belongs to the same group in the dimeric form. Series of experiments with varying delays between the inverting and reading pulses were carried out. All the experimental details and data analysis are provided in the <xref ref-type="supplementary-material" rid="S1">supplementary material (pages S24-S28)</xref>.</p>
      </sec>
      <sec disp-level="2">
        <title>NMR restrains</title>
        <p>NOE distance restraints used in structure calculation of the dimeric form of Zn-H6R-ÐÎ²<sub>1â16</sub> complex were obtained from 2D NOESY spectra acquired at 274âK in H<sub>2</sub>O or at 278âK in D<sub>2</sub>O. NMR signal assignment of ZnÂ·Â·Â·H6R-ÐÎ²<sub>1â16</sub> complex was reported earlier<xref ref-type="bibr" rid="b36">36</xref>. Representative fragment of the NOESY spectrum with some principal assignments is shown on <xref ref-type="fig" rid="f5">Fig. 5</xref>. Signal intensities in NOESY spectra were calibrated and converted into the distance restrains using the fixed distance intraresidue NOEs as the reference. Distance and torsion angle restraints representing the coordination site of zinc ion were obtained using the quantum mechanical calculations (see below).</p>
      </sec>
      <sec disp-level="2">
        <title>QM/MM and restrained molecular dynamics</title>
        <p>Structures of the complex of H6R-ÐÎ²<sub>1â16</sub> with zinc ions were determined using the GROMACS 3.3.1 software<xref ref-type="bibr" rid="b70">70</xref>, AMBER 03 force field<xref ref-type="bibr" rid="b71">71</xref> and optimized protocol of the simulated annealing MD calculations<xref ref-type="bibr" rid="b47">47</xref><xref ref-type="bibr" rid="b51">51</xref> with the set of distance restraints listed in <xref ref-type="table" rid="t2">Table 2</xref>. QM/MM CarâParrinello simulation approach<xref ref-type="bibr" rid="b72">72</xref><xref ref-type="bibr" rid="b73">73</xref> was applied to optimize the zinc binding site and to obtain restrains that describe geometry of Zn<sup>2+</sup> coordination center. All the parameters and protocols of the MD and QM/MM calculations were described earlier in detail<xref ref-type="bibr" rid="b47">47</xref>. Convergence of the calculations was determined using root mean square deviation (RMSD) of the coordinates of the C, CÎ±, and N atoms of protein backbone, calculated for the whole family of structures. Quality of the calculated structures was defined on the basis of the percent of hits of the main dihedral angles Ï and Ï in the most favorable and prohibited areas of Ramachandran map using Procheck_NMR<xref ref-type="bibr" rid="b74">74</xref>. Structures were visualized and analyzed using the InsightII or Discovery Studio software (Accelrys Inc.).</p>
      </sec>
      <sec disp-level="2">
        <title>MD simulations</title>
        <p>Molecular modeling has been performed for homodimer AÎ²<sub>1â16</sub>Â·AÎ²<sub>1â16</sub> and heterodimer AÎ²<sub>1â16</sub>Â·isoD7-AÎ²<sub>1â16</sub> using the representative NMR conformer of the H6R-AÎ²<sub>1â16</sub> dimer as initial structure. Homology modeling was performed using the Chimera software<xref ref-type="bibr" rid="b75">75</xref>. Partial charges for the non-standard residue isoD7 were assigned using the AM1-BCC method<xref ref-type="bibr" rid="b76">76</xref>. Initial models were refined using the restrained molecular dynamic simulation with GROMACS 4.6.5 software<xref ref-type="bibr" rid="b70">70</xref> and Amber99SB-ILDN force field<xref ref-type="bibr" rid="b77">77</xref>. Peptide dimers were placed in the cubic cell with a minimum distance (0.8ânm) between a protein and the box wall and soaked with TIP3P water molecules<xref ref-type="bibr" rid="b78">78</xref>. Total charge of the solution has been neutralized with sodium ions. Energy was minimized using the steepest descent algorithm and the system was further equilibrated during 100 ps of constant volume (NVT) molecular dynamic simulation followed by 100 ps of constant pressure (NPT) molecular dynamics. 10âns MD simulations were carried out using the NPT ensemble to relax protein chains. 6âÃ restraint has been applied to the distance between H6 NÎµ2 and H13 NÎµ2 atoms. 20âns NPT MD simulations were performed to follow approaching of imidazole rings of H6 and H13. Position of the side chains of residues E11 and H14 together with the coordinated zinc ion were restrained during all simulation steps. Calculations were performed at 300âK, pressure 1 bar, with a 2âfs integration step using Berendsen barostat and velocity rescale method for thermostat. Particle-mesh Ewald method<xref ref-type="bibr" rid="b79">79</xref> has been implemented to treat long-range electrostatic interactions, and LINCS algorithm to control the lengths of covalent bonds<xref ref-type="bibr" rid="b80">80</xref>.</p>
      </sec>
    </sec>
    <sec disp-level="1">
      <title>Additional Information</title>
      <p><bold>Accession Code</bold>: The structural data and experimental restraints used in the calculations have been submitted to the Protein Data Bank with accession number 2MGT.</p>
      <p><bold>How to cite this article</bold>: Istrate, A. N. <italic>et al.</italic> Interplay of histidine residues of the Alzheimer's disease AÎ² peptide governs its Zn-induced oligomerization. <italic>Sci. Rep.</italic>
<bold>6</bold>, 21734; doi: 10.1038/srep21734 (2016).</p>
    </sec>
    <sec sec-type="supplementary-material" id="S1">
      <title>Supplementary Material</title>
      <supplementary-material id="d33e27" content-type="local-data">
        <caption>
          <title>Supplementary Information</title>
        </caption>
        <media xlink:href="srep21734-s1.pdf"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>This work was supported by the Russian Science Foundation grant â 14-24-00100. Authors are grateful to the Moscow State University (Russia) for the opportunity to use the NMR facilities and the supercomputer SKIF Chebyshev, and the MRC Biomedical NMR Centre (UK) for the opportunity to use the NMR facilities. Authors are grateful to Alexei A. Adzhubei for useful discussions.</p>
    </ack>
    <ref-list>
      <ref id="b1">
        <mixed-citation publication-type="journal"><name><surname>Hardy</surname><given-names>J.</given-names></name> &amp; <name><surname>Selkoe</surname><given-names>D. J.</given-names></name>
<article-title>The amyloid hypothesis of Alzheimerâs disease: progress and problems on the road to therapeutics</article-title>. <source>Science</source>
<volume>297</volume>, <fpage>353</fpage>â<lpage>356</lpage>, <pub-id pub-id-type="doi">10.1126/science.1072994</pub-id> (<year>2002</year>).<pub-id pub-id-type="pmid">12130773</pub-id></mixed-citation>
      </ref>
      <ref id="b2">
        <mixed-citation publication-type="journal"><name><surname>Musiek</surname><given-names>E. S.</given-names></name> &amp; <name><surname>Holtzman</surname><given-names>D. M.</given-names></name>
<article-title>Three dimensions of the amyloid hypothesis: time, space and âwingmenâ</article-title>. <source>Nat Neurosci</source>
<volume>18</volume>, <fpage>800</fpage>â<lpage>806</lpage>, <pub-id pub-id-type="doi">10.1038/nn.4018</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">26007213</pub-id></mixed-citation>
      </ref>
      <ref id="b3">
        <mixed-citation publication-type="journal"><name><surname>Meyer-Luehmann</surname><given-names>M.</given-names></name>
<italic>et al.</italic>
<article-title>Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host</article-title>. <source>Science</source>
<volume>313</volume>, <fpage>1781</fpage>â<lpage>1784</lpage>, <pub-id pub-id-type="doi">10.1126/science.1131864</pub-id> (<year>2006</year>).<pub-id pub-id-type="pmid">16990547</pub-id></mixed-citation>
      </ref>
      <ref id="b4">
        <mixed-citation publication-type="journal"><name><surname>Ayton</surname><given-names>S.</given-names></name>, <name><surname>Lei</surname><given-names>P.</given-names></name> &amp; <name><surname>Bush</surname><given-names>A.</given-names></name>
<article-title>Biometals and Their Therapeutic Implications in Alzheimerâs Disease</article-title>. <source>Neurotherapeutics</source>
<volume>12</volume>, <fpage>109</fpage>â<lpage>120</lpage>, <pub-id pub-id-type="doi">10.1007/s13311-014-0312-z</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">25354461</pub-id></mixed-citation>
      </ref>
      <ref id="b5">
        <mixed-citation publication-type="journal"><name><surname>Ballard</surname><given-names>C.</given-names></name>
<italic>et al.</italic>
<article-title>Alzheimerâs disease</article-title>. <source>Lancet</source>
<volume>377</volume>, <fpage>1019</fpage>â<lpage>1031</lpage>, <pub-id pub-id-type="doi">10.1016/S0140-6736(10)61349-9</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21371747</pub-id></mixed-citation>
      </ref>
      <ref id="b6">
        <mixed-citation publication-type="journal"><name><surname>Hamley</surname><given-names>I. W.</given-names></name>
<article-title>The Amyloid Beta Peptide: A Chemistâs Perspective. Role in Alzheimerâs and Fibrillization</article-title>. <source>Chem Rev</source>
<volume>112</volume>, <fpage>5147</fpage>â<lpage>5192</lpage>, <pub-id pub-id-type="doi">10.1021/cr3000994</pub-id> (<year>2012</year>).<pub-id pub-id-type="pmid">22813427</pub-id></mixed-citation>
      </ref>
      <ref id="b7">
        <mixed-citation publication-type="journal"><name><surname>Bush</surname><given-names>A. I.</given-names></name>
<article-title>The Metal Theory of Alzheimerâs Disease</article-title>. <source>J Alzheimerâs Disease</source>
<volume>33</volume>, <fpage>S277</fpage>â<lpage>S281</lpage>, <pub-id pub-id-type="doi">10.3233/jad-2012-129011</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">22635102</pub-id></mixed-citation>
      </ref>
      <ref id="b8">
        <mixed-citation publication-type="journal"><name><surname>Deshpande</surname><given-names>A.</given-names></name>, <name><surname>Kawai</surname><given-names>H.</given-names></name>, <name><surname>Metherate</surname><given-names>R.</given-names></name>, <name><surname>Glabe</surname><given-names>C. G.</given-names></name> &amp; <name><surname>Busciglio</surname><given-names>J.</given-names></name>
<article-title>A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses</article-title>. <source>The Journal of neuroscience : the official journal of the Society for Neuroscience</source>
<volume>29</volume>, <fpage>4004</fpage>â<lpage>4015</lpage>, <pub-id pub-id-type="doi">10.1523/jneurosci.5980-08.2009</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19339596</pub-id></mixed-citation>
      </ref>
      <ref id="b9">
        <mixed-citation publication-type="journal"><name><surname>Lovell</surname><given-names>M. A.</given-names></name>, <name><surname>Robertson</surname><given-names>J. D.</given-names></name>, <name><surname>Teesdale</surname><given-names>W. J.</given-names></name>, <name><surname>Campbell</surname><given-names>J. L.</given-names></name> &amp; <name><surname>Markesbery</surname><given-names>W. R.</given-names></name>
<article-title>Copper, iron and zinc in Alzheimerâs disease senile plaques</article-title>. <source>J. Neurol. Sci.</source>
<volume>158</volume>, <fpage>47</fpage>â<lpage>52</lpage>, S0022-510X(98)00092-6 [pii] (<year>1998</year>).<pub-id pub-id-type="pmid">9667777</pub-id></mixed-citation>
      </ref>
      <ref id="b10">
        <mixed-citation publication-type="journal"><name><surname>Suh</surname><given-names>S. W.</given-names></name>
<italic>et al.</italic>
<article-title>Histochemically-reactive zinc in amyloid plaques, angiopathy and degenerating neurons of Alzheimerâs diseased brains</article-title>. <source>Brain Res</source>
<volume>852</volume>, <fpage>274</fpage>â<lpage>278</lpage>, <pub-id pub-id-type="doi">10.1016/S0006-8993(99)02096-X</pub-id> (<year>2000</year>).<pub-id pub-id-type="pmid">10678753</pub-id></mixed-citation>
      </ref>
      <ref id="b11">
        <mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>Y.</given-names></name>, <name><surname>Ma</surname><given-names>B.</given-names></name> &amp; <name><surname>Nussinov</surname><given-names>R.</given-names></name>
<article-title>Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>
<volume>107</volume>, <fpage>9490</fpage>â<lpage>9495</lpage>, <pub-id pub-id-type="doi">10.1073/pnas.0913114107</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20448202</pub-id></mixed-citation>
      </ref>
      <ref id="b12">
        <mixed-citation publication-type="journal"><name><surname>Iannuzzi</surname><given-names>C.</given-names></name>
<italic>et al.</italic>
<article-title>The role of zinc in the stability of the marginally stable IscU scaffold protein</article-title>. <source>Prot Sci</source>
<volume>23</volume>, <fpage>1208</fpage>â<lpage>1219</lpage>, <pub-id pub-id-type="doi">10.1002/pro.2501</pub-id> (<year>2014</year>).</mixed-citation>
      </ref>
      <ref id="b13">
        <mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>K. H.</given-names></name>, <name><surname>Kim</surname><given-names>Y. K.</given-names></name> &amp; <name><surname>Chang</surname><given-names>Y.-T.</given-names></name>
<article-title>Investigations of the Molecular Mechanism of Metal-Induced AÎ² (1â40) Amyloidogenesis</article-title>. <source>Biochemistry</source>
<volume>46</volume>, <fpage>13523</fpage>â<lpage>13532</lpage>, <pub-id pub-id-type="doi">10.1021/bi701112z</pub-id> (<year>2007</year>).<pub-id pub-id-type="pmid">17973493</pub-id></mixed-citation>
      </ref>
      <ref id="b14">
        <mixed-citation publication-type="journal"><name><surname>Nasica-Labouze</surname><given-names>J.</given-names></name>
<italic>et al.</italic>
<article-title>Amyloid Î² Protein and Alzheimerâs Disease: When Computer Simulations Complement Experimental Studies</article-title>. <source>Chem Rev</source>
<volume>115</volume>, <fpage>3518</fpage>â<lpage>3563</lpage>, <pub-id pub-id-type="doi">10.1021/cr500638n</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">25789869</pub-id></mixed-citation>
      </ref>
      <ref id="b15">
        <mixed-citation publication-type="journal"><name><surname>Faller</surname><given-names>P.</given-names></name> &amp; <name><surname>Hureau</surname><given-names>C.</given-names></name>
<article-title>Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide</article-title>. <source>Dalton Trans</source>, <fpage>1080</fpage>â<lpage>1094</lpage>, <pub-id pub-id-type="doi">10.1039/b813398k</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19322475</pub-id></mixed-citation>
      </ref>
      <ref id="b16">
        <mixed-citation publication-type="journal"><name><surname>Kozin</surname><given-names>S. A.</given-names></name>, <name><surname>Zirah</surname><given-names>S.</given-names></name>, <name><surname>Rebuffat</surname><given-names>S.</given-names></name>, <name><surname>Hoa</surname><given-names>G. H.</given-names></name> &amp; <name><surname>Debey</surname><given-names>P.</given-names></name>
<article-title>Zinc binding to Alzheimerâs Abeta(1â16) peptide results in stable soluble complex</article-title>. <source>Biochem Biophys Res Commun</source>
<volume>285</volume>, <fpage>959</fpage>â<lpage>964</lpage>, <pub-id pub-id-type="doi">10.1006/bbrc.2001.5284</pub-id> (<year>2001</year>).<pub-id pub-id-type="pmid">11467845</pub-id></mixed-citation>
      </ref>
      <ref id="b17">
        <mixed-citation publication-type="journal"><name><surname>Zirah</surname><given-names>S.</given-names></name>
<italic>et al.</italic>
<article-title>Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and <italic>in vitro</italic> aging</article-title>. <source>J Biol Chem</source>
<volume>281</volume>, <fpage>2151</fpage>â<lpage>2161</lpage>, <pub-id pub-id-type="doi">10.1074/jbc.M504454200</pub-id> (<year>2006</year>).<pub-id pub-id-type="pmid">16301322</pub-id></mixed-citation>
      </ref>
      <ref id="b18">
        <mixed-citation publication-type="journal"><name><surname>Portelius</surname><given-names>E.</given-names></name>
<italic>et al.</italic>
<article-title>A novel pathway for amyloid precursor protein processing</article-title>. <source>Neurobiol Aging</source>
<volume>32</volume>, <fpage>1090</fpage>â<lpage>1098</lpage>, <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.06.002</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">19604603</pub-id></mixed-citation>
      </ref>
      <ref id="b19">
        <mixed-citation publication-type="journal"><name><surname>Colvin</surname><given-names>M. T.</given-names></name>
<italic>et al.</italic>
<article-title>High Resolution Structural Characterization of Abeta42 Amyloid Fibrils by Magic Angle Spinning NMR</article-title>. <source>J Am Chem Soc</source>
<volume>137</volume>, <fpage>7509</fpage>â<lpage>7518</lpage>, <pub-id pub-id-type="doi">10.1021/jacs.5b03997</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">26001057</pub-id></mixed-citation>
      </ref>
      <ref id="b20">
        <mixed-citation publication-type="journal"><name><surname>Luhrs</surname><given-names>T.</given-names></name>
<italic>et al.</italic>
<article-title>3D structure of Alzheimerâs amyloid-beta(1â42) fibrils</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>102</volume>, <fpage>17342</fpage>â<lpage>17347</lpage>, <pub-id pub-id-type="doi">10.1073/pnas.0506723102</pub-id> (<year>2005</year>).<pub-id pub-id-type="pmid">16293696</pub-id></mixed-citation>
      </ref>
      <ref id="b21">
        <mixed-citation publication-type="journal"><name><surname>Talmard</surname><given-names>C.</given-names></name>, <name><surname>Guilloreau</surname><given-names>L.</given-names></name>, <name><surname>Coppel</surname><given-names>Y.</given-names></name>, <name><surname>Mazarguil</surname><given-names>H.</given-names></name> &amp; <name><surname>Faller</surname><given-names>P.</given-names></name>
<article-title>Amyloid-beta peptide forms monomeric complexes with Cu(II) and Zn(II) prior to aggregation</article-title>. <source>Chembiochem</source>
<volume>8</volume>, <fpage>163</fpage>â<lpage>165</lpage>, <pub-id pub-id-type="doi">10.1002/cbic.200600319</pub-id> (<year>2007</year>).<pub-id pub-id-type="pmid">17195250</pub-id></mixed-citation>
      </ref>
      <ref id="b22">
        <mixed-citation publication-type="journal"><name><surname>Barrow</surname><given-names>C. J.</given-names></name> &amp; <name><surname>Zagorski</surname><given-names>M. G.</given-names></name>
<article-title>Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition</article-title>. <source>Science</source>
<volume>253</volume>, <fpage>179</fpage>â<lpage>182</lpage>, <pub-id pub-id-type="doi">10.1126/science.1853202</pub-id> (<year>1991</year>).<pub-id pub-id-type="pmid">1853202</pub-id></mixed-citation>
      </ref>
      <ref id="b23">
        <mixed-citation publication-type="journal"><name><surname>Coles</surname><given-names>M.</given-names></name>, <name><surname>Bicknell</surname><given-names>W.</given-names></name>, <name><surname>Watson</surname><given-names>A. A.</given-names></name>, <name><surname>Fairlie</surname><given-names>D. P.</given-names></name> &amp; <name><surname>Craik</surname><given-names>D. J.</given-names></name>
<article-title>Solution structure of amyloid beta-peptide(1â40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?</article-title>
<source>Biochemistry</source>
<volume>37</volume>, <fpage>11064</fpage>â<lpage>11077</lpage>, <pub-id pub-id-type="doi">10.1021/bi972979f</pub-id> (<year>1998</year>).<pub-id pub-id-type="pmid">9693002</pub-id></mixed-citation>
      </ref>
      <ref id="b24">
        <mixed-citation publication-type="journal"><name><surname>Crescenzi</surname><given-names>O.</given-names></name>
<italic>et al.</italic>
<article-title>Solution structure of the Alzheimer amyloid beta-peptide (1â42) in an apolar microenvironment. Similarity with a virus fusion domain</article-title>. <source>Eur J Biochem</source>
<volume>269</volume>, <fpage>5642</fpage>â<lpage>5648</lpage>, <pub-id pub-id-type="doi">10.1046/j.1432-1033.2002.03271.x</pub-id> (<year>2002</year>).<pub-id pub-id-type="pmid">12423364</pub-id></mixed-citation>
      </ref>
      <ref id="b25">
        <mixed-citation publication-type="journal"><name><surname>Danielsson</surname><given-names>J.</given-names></name>, <name><surname>Andersson</surname><given-names>A.</given-names></name>, <name><surname>Jarvet</surname><given-names>J.</given-names></name> &amp; <name><surname>Graslund</surname><given-names>A.</given-names></name>
<article-title>15N relaxation study of the amyloid beta-peptide: structural propensities and persistence length</article-title>. <source>Magnetic resonance in chemistry: MRC</source>
<volume>44</volume> Spec No, <fpage>S114</fpage>â<lpage>121</lpage>, <pub-id pub-id-type="doi">10.1002/mrc.1814</pub-id> (<year>2006</year>).<pub-id pub-id-type="pmid">16826550</pub-id></mixed-citation>
      </ref>
      <ref id="b26">
        <mixed-citation publication-type="journal"><name><surname>Eker</surname><given-names>F.</given-names></name>, <name><surname>Griebenow</surname><given-names>K.</given-names></name> &amp; <name><surname>Schweitzer-Stenner</surname><given-names>R.</given-names></name>
<article-title>AÎ²(1â28) Fragment of the Amyloid Peptide Predominantly Adopts a Polyproline II Conformation in an Acidic Solution<sup>â </sup></article-title>. <source>Biochemistry</source>
<volume>43</volume>, <fpage>6893</fpage>â<lpage>6898</lpage>, <pub-id pub-id-type="doi">10.1021/bi049542+</pub-id> (<year>2004</year>).<pub-id pub-id-type="pmid">15170326</pub-id></mixed-citation>
      </ref>
      <ref id="b27">
        <mixed-citation publication-type="journal"><name><surname>Jarvet</surname><given-names>J.</given-names></name>
<italic>et al.</italic>
<article-title>A left-handed 3(1) helical conformation in the Alzheimer Abeta(12â28) peptide</article-title>. <source>FEBS Lett</source>
<volume>555</volume>, <fpage>371</fpage>â<lpage>374</lpage>, <pub-id pub-id-type="doi">10.1016/S0014-5793(03)01293-6</pub-id> (<year>2003</year>).<pub-id pub-id-type="pmid">14644445</pub-id></mixed-citation>
      </ref>
      <ref id="b28">
        <mixed-citation publication-type="journal"><name><surname>Petkova</surname><given-names>A. T.</given-names></name>
<italic>et al.</italic>
<article-title>A structural model for Alzheimerâs beta -amyloid fibrils based on experimental constraints from solid state NMR</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>99</volume>, <fpage>16742</fpage>â<lpage>16747</lpage>, <pub-id pub-id-type="doi">10.1073/pnas.262663499</pub-id> (<year>2002</year>).<pub-id pub-id-type="pmid">12481027</pub-id></mixed-citation>
      </ref>
      <ref id="b29">
        <mixed-citation publication-type="journal"><name><surname>Shao</surname><given-names>H.</given-names></name>, <name><surname>Jao</surname><given-names>S.</given-names></name>, <name><surname>Ma</surname><given-names>K.</given-names></name> &amp; <name><surname>Zagorski</surname><given-names>M. G.</given-names></name>
<article-title>Solution structures of micelle-bound amyloid beta-(1â40) and beta-(1â42) peptides of Alzheimerâs disease</article-title>. <source>J Mol Biol</source>
<volume>285</volume>, <fpage>755</fpage>â<lpage>773</lpage>, <pub-id pub-id-type="doi">10.1006/jmbi.1998.2348</pub-id> (<year>1999</year>).<pub-id pub-id-type="pmid">9878442</pub-id></mixed-citation>
      </ref>
      <ref id="b30">
        <mixed-citation publication-type="journal"><name><surname>Sticht</surname><given-names>H.</given-names></name>
<italic>et al.</italic>
<article-title>Structure of amyloid A4-(1â40)-peptide of Alzheimerâs disease</article-title>. <source>Eur J Biochem</source>
<volume>233</volume>, <fpage>293</fpage>â<lpage>298</lpage>, <pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.293_1.x</pub-id> (<year>1995</year>).<pub-id pub-id-type="pmid">7588758</pub-id></mixed-citation>
      </ref>
      <ref id="b31">
        <mixed-citation publication-type="journal"><name><surname>Nisbet</surname><given-names>R. M.</given-names></name>
<italic>et al.</italic>
<article-title>Structural studies of the tethered N-terminus of the Alzheimerâs disease amyloid-Î² peptide</article-title>. <source>Prot: Struct Funct Bioinform</source>
<volume>81</volume>, <fpage>1748</fpage>â<lpage>1758</lpage>, <pub-id pub-id-type="doi">10.1002/prot.24312</pub-id> (<year>2013</year>).</mixed-citation>
      </ref>
      <ref id="b32">
        <mixed-citation publication-type="journal"><name><surname>Cavalli</surname><given-names>S.</given-names></name>, <name><surname>Albericio</surname><given-names>F.</given-names></name> &amp; <name><surname>Kros</surname><given-names>A.</given-names></name>
<article-title>Amphiphilic peptides and their cross-disciplinary role as building blocks for nanoscience</article-title>. <source>Chemical Society reviews</source>
<volume>39</volume>, <fpage>241</fpage>â<lpage>263</lpage>, <pub-id pub-id-type="doi">10.1039/b906701a</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20023851</pub-id></mixed-citation>
      </ref>
      <ref id="b33">
        <mixed-citation publication-type="journal"><name><surname>Furlan</surname><given-names>S.</given-names></name>, <name><surname>Hureau</surname><given-names>C.</given-names></name>, <name><surname>Faller</surname><given-names>P.</given-names></name> &amp; <name><surname>La Penna</surname><given-names>G.</given-names></name>
<article-title>Modeling the Cu+ binding in the 1â16 region of the amyloid-beta peptide involved in Alzheimerâs disease</article-title>. <source>J Phys Chem B</source>
<volume>114</volume>, <fpage>15119</fpage>â<lpage>15133</lpage>, <pub-id pub-id-type="doi">10.1021/jp102928h</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">21038888</pub-id></mixed-citation>
      </ref>
      <ref id="b34">
        <mixed-citation publication-type="journal"><name><surname>Tsvetkov</surname><given-names>P. O.</given-names></name>
<italic>et al.</italic>
<article-title>Minimal Zn(2+) binding site of amyloid-beta</article-title>. <source>Biophys J</source>
<volume>99</volume>, <fpage>L84</fpage>â<lpage>86</lpage>, <pub-id pub-id-type="doi">10.1016/j.bpj.2010.09.015</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">21081056</pub-id></mixed-citation>
      </ref>
      <ref id="b35">
        <mixed-citation publication-type="journal"><name><surname>Mezentsev</surname><given-names>Y. V.</given-names></name>
<italic>et al.</italic>
<article-title>Zinc-induced heterodimer formation between metal-binding domains of intact and naturally modified amyloid-beta species: implication to amyloid seeding in Alzheimerâs disease?</article-title>
<source>J Biomol Struct Dyn</source>, <fpage>1</fpage>â<lpage>34</lpage>, <pub-id pub-id-type="doi">10.1080/07391102.2015.1113890</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">26513486</pub-id></mixed-citation>
      </ref>
      <ref id="b36">
        <mixed-citation publication-type="journal"><name><surname>Kozin</surname><given-names>S. A.</given-names></name>
<italic>et al.</italic>
<article-title>The English (H6R) familial Alzheimerâs disease mutation facilitates zinc-induced dimerization of the amyloid-beta metal-binding domain</article-title>. <source>Metallomics</source>
<volume>7</volume>, <fpage>422</fpage>â<lpage>425</lpage>, <pub-id pub-id-type="doi">10.1039/c4mt00259h</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">25703165</pub-id></mixed-citation>
      </ref>
      <ref id="b37">
        <mixed-citation publication-type="journal"><name><surname>Kozin</surname><given-names>S. A.</given-names></name>
<italic>et al.</italic>
<article-title>Zinc-induced dimerization of the amyloid-beta metal-binding domain 1â16 is mediated by residues 11â14</article-title>. <source>Mol Biosyst</source>
<volume>7</volume>, <fpage>1053</fpage>â<lpage>1055</lpage>, <pub-id pub-id-type="doi">10.1039/c0mb00334d</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21350790</pub-id></mixed-citation>
      </ref>
      <ref id="b38">
        <mixed-citation publication-type="journal"><name><surname>Kulikova</surname><given-names>A. A.</given-names></name>
<italic>et al.</italic>
<article-title>Phosphorylation of Ser8 promotes zinc-induced dimerization of the amyloid-beta metal-binding domain</article-title>. <source>Mol Biosyst</source>
<volume>10</volume>, <fpage>2590</fpage>â<lpage>2596</lpage>, <pub-id pub-id-type="doi">10.1039/c4mb00332b</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">25023775</pub-id></mixed-citation>
      </ref>
      <ref id="b39">
        <mixed-citation publication-type="journal"><name><surname>Masters</surname><given-names>C. L.</given-names></name> &amp; <name><surname>Selkoe</surname><given-names>D. J.</given-names></name>
<article-title>Biochemistry of amyloid beta-protein and amyloid deposits in Alzheimer disease</article-title>. <source>Cold Spring Harbor perspectives in medicine</source>
<volume>2</volume>, <fpage>a006262</fpage>, <pub-id pub-id-type="doi">10.1101/cshperspect.a006262</pub-id> (<year>2012</year>).<pub-id pub-id-type="pmid">22675658</pub-id></mixed-citation>
      </ref>
      <ref id="b40">
        <mixed-citation publication-type="journal"><name><surname>Jucker</surname><given-names>M.</given-names></name> &amp; <name><surname>Walker</surname><given-names>L. C.</given-names></name>
<article-title>Self-propagation of pathogenic protein aggregates in neurodegenerative diseases</article-title>. <source>Nature</source>
<volume>501</volume>, <fpage>45</fpage>â<lpage>51</lpage>, <pub-id pub-id-type="doi">10.1038/nature12481</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">24005412</pub-id></mixed-citation>
      </ref>
      <ref id="b41">
        <mixed-citation publication-type="journal"><name><surname>StÃ¶hr</surname><given-names>J.</given-names></name>
<italic>et al.</italic>
<article-title>Purified and synthetic Alzheimerâs amyloid beta (Abeta) prions</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>109</volume>, <fpage>11025</fpage>â<lpage>11030</lpage>, <pub-id pub-id-type="doi">10.1073/pnas.1206555109</pub-id> (<year>2012</year>).<pub-id pub-id-type="pmid">22711819</pub-id></mixed-citation>
      </ref>
      <ref id="b42">
        <mixed-citation publication-type="journal"><name><surname>Kummer</surname><given-names>M. P.</given-names></name> &amp; <name><surname>Heneka</surname><given-names>M. T.</given-names></name>
<article-title>Truncated and modified amyloid-beta species</article-title>. <source>Alzheimerâs research &amp; therapy</source>
<volume>6</volume>, <fpage>28</fpage>, <pub-id pub-id-type="doi">10.1186/alzrt258</pub-id> (<year>2014</year>).</mixed-citation>
      </ref>
      <ref id="b43">
        <mixed-citation publication-type="journal"><name><surname>Tsvetkov</surname><given-names>P. O.</given-names></name>
<italic>et al.</italic>
<article-title>Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimerâs disease amyloid beta(1â16) peptide</article-title>. <source>Chembiochem</source>
<volume>9</volume>, <fpage>1564</fpage>â<lpage>1567</lpage>, <pub-id pub-id-type="doi">10.1002/cbic.200700784</pub-id> (<year>2008</year>).<pub-id pub-id-type="pmid">18506864</pub-id></mixed-citation>
      </ref>
      <ref id="b44">
        <mixed-citation publication-type="journal"><name><surname>Kozin</surname><given-names>S. A.</given-names></name>
<italic>et al.</italic>
<article-title>Peripherally applied synthetic peptide isoAsp7-Abeta(1â42) triggers cerebral beta-amyloidosis</article-title>. <source>Neurotoxicity research</source>
<volume>24</volume>, <fpage>370</fpage>â<lpage>376</lpage>, <pub-id pub-id-type="doi">10.1007/s12640-013-9399-y</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">23670398</pub-id></mixed-citation>
      </ref>
      <ref id="b45">
        <mixed-citation publication-type="journal"><name><surname>Faller</surname><given-names>P.</given-names></name>, <name><surname>Hureau</surname><given-names>C.</given-names></name> &amp; <name><surname>La Penna</surname><given-names>G.</given-names></name>
<article-title>Metal Ions and Intrinsically Disordered Proteins and Peptides: From Cu/Zn Amyloid-Î² to General Principles</article-title>. <source>Acc Chem Res</source>
<volume>47</volume>, <fpage>2252</fpage>â<lpage>2259</lpage>, <pub-id pub-id-type="doi">10.1021/ar400293h</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">24871565</pub-id></mixed-citation>
      </ref>
      <ref id="b46">
        <mixed-citation publication-type="journal"><name><surname>Curtain</surname><given-names>C. C.</given-names></name>
<italic>et al.</italic>
<article-title>Alzheimerâs disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits</article-title>. <source>J Biol Chem</source>
<volume>276</volume>, <fpage>20466</fpage>â<lpage>20473</lpage>, <pub-id pub-id-type="doi">10.1074/jbc.M100175200</pub-id> (<year>2001</year>).<pub-id pub-id-type="pmid">11274207</pub-id></mixed-citation>
      </ref>
      <ref id="b47">
        <mixed-citation publication-type="journal"><name><surname>Istrate</surname><given-names>A. N.</given-names></name>
<italic>et al.</italic>
<article-title>NMR Solution Structure of Rat A beta(1â16): Toward Understanding the Mechanism of Ratsâ Resistance to Alzheimerâs Disease</article-title>. <source>Biophys J</source>
<volume>102</volume>, <fpage>136</fpage>â<lpage>143</lpage>, DOI <pub-id pub-id-type="doi">10.1016/j.bpj.2011.11.4006</pub-id> (<year>2012</year>).<pub-id pub-id-type="pmid">22225807</pub-id></mixed-citation>
      </ref>
      <ref id="b48">
        <mixed-citation publication-type="journal"><name><surname>Syme</surname><given-names>C. D.</given-names></name> &amp; <name><surname>Viles</surname><given-names>J. H.</given-names></name>
<article-title>Solution <sup>1</sup>H NMR investigation of Zn<sup>2+</sup> and Cd<sup>2+</sup> binding to amyloid-beta peptide (Abeta) of Alzheimerâs disease</article-title>. <source>Biochim Biophys Acta</source>
<volume>1764</volume>, <fpage>246</fpage>â<lpage>256</lpage>, <pub-id pub-id-type="doi">10.1016/j.bbapap.2005.09.012</pub-id> (<year>2006</year>).<pub-id pub-id-type="pmid">16266835</pub-id></mixed-citation>
      </ref>
      <ref id="b49">
        <mixed-citation publication-type="journal"><name><surname>Post</surname><given-names>C. B.</given-names></name> &amp; <name><surname>Exchange-transferred</surname><given-names>NOE</given-names></name>
<article-title>spectroscopy and bound ligand structure determination</article-title>. <source>Curr Opin Struct Biol</source>
<volume>13</volume>, <fpage>581</fpage>â<lpage>588</lpage>, <pub-id pub-id-type="doi">10.1016/j.sbi.2003.09.012</pub-id> (<year>2003</year>).<pub-id pub-id-type="pmid">14568612</pub-id></mixed-citation>
      </ref>
      <ref id="b50">
        <mixed-citation publication-type="journal"><name><surname>Dudev</surname><given-names>T.</given-names></name> &amp; <name><surname>Lim</surname><given-names>C.</given-names></name>
<article-title>Principles governing Mg, Ca and Zn binding and selectivity in proteins</article-title>. <source>Chemical Reviews</source>
<volume>103</volume>, <fpage>773</fpage>â<lpage>787</lpage>, <pub-id pub-id-type="doi">10.1021/cr020467n</pub-id> (<year>2003</year>).<pub-id pub-id-type="pmid">12630852</pub-id></mixed-citation>
      </ref>
      <ref id="b51">
        <mixed-citation publication-type="journal"><name><surname>Istrate</surname><given-names>A. N.</given-names></name>, <name><surname>Mantsyzov</surname><given-names>A. B.</given-names></name>, <name><surname>Kozin</surname><given-names>S. A.</given-names></name> &amp; <name><surname>Polshakov</surname><given-names>V. I.</given-names></name>
<article-title>Optimization of the methods for small peptide solution structure determination by NMR spectroscopy</article-title>. <source>Mol. Biol.</source>
<volume>44</volume>, <fpage>958</fpage>â<lpage>967</lpage>, <pub-id pub-id-type="doi">10.1134/S0026893310060130</pub-id> (<year>2010</year>).</mixed-citation>
      </ref>
      <ref id="b52">
        <mixed-citation publication-type="journal"><name><surname>Fielding</surname><given-names>L.</given-names></name>
<article-title>Determination of association constants (K<sub>a</sub>) from solution NMR data</article-title>. <source>Tetrahedron</source>
<volume>56</volume>, <fpage>6151</fpage>â<lpage>6170</lpage>, <pub-id pub-id-type="doi">10.1016/S0040-4020(00)00492-0</pub-id> (<year>2000</year>).</mixed-citation>
      </ref>
      <ref id="b53">
        <mixed-citation publication-type="journal"><name><surname>Querfurth</surname><given-names>H. W.</given-names></name> &amp; <name><surname>LaFerla</surname><given-names>F. M.</given-names></name>
<article-title>Alzheimerâs disease</article-title>. <source>N Engl J Med</source>
<volume>362</volume>, <fpage>329</fpage>â<lpage>344</lpage>, <pub-id pub-id-type="doi">10.1056/NEJMra0909142</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20107219</pub-id></mixed-citation>
      </ref>
      <ref id="b54">
        <mixed-citation publication-type="journal"><name><surname>WÃ¤lti</surname><given-names>M. A.</given-names></name>, <name><surname>Orts</surname><given-names>J.</given-names></name>, <name><surname>Vogeli</surname><given-names>B.</given-names></name>, <name><surname>Campioni</surname><given-names>S.</given-names></name> &amp; <name><surname>Riek</surname><given-names>R.</given-names></name>
<article-title>Solution NMR studies of recombinant Abeta(1â42): from the presence of a micellar entity to residual beta-sheet structure in the soluble species</article-title>. <source>Chembiochem</source>
<volume>16</volume>, <fpage>659</fpage>â<lpage>669</lpage>, <pub-id pub-id-type="doi">10.1002/cbic.201402595</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">25676345</pub-id></mixed-citation>
      </ref>
      <ref id="b55">
        <mixed-citation publication-type="journal"><name><surname>Bertini</surname><given-names>I.</given-names></name>, <name><surname>Gonnelli</surname><given-names>L.</given-names></name>, <name><surname>Luchinat</surname><given-names>C.</given-names></name>, <name><surname>Mao</surname><given-names>J.</given-names></name> &amp; <name><surname>Nesi</surname><given-names>A.</given-names></name>
<article-title>A new structural model of Abeta40 fibrils</article-title>. <source>J Am Chem Soc</source>
<volume>133</volume>, <fpage>16013</fpage>â<lpage>16022</lpage>, <pub-id pub-id-type="doi">10.1021/ja2035859</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21882806</pub-id></mixed-citation>
      </ref>
      <ref id="b56">
        <mixed-citation publication-type="journal"><name><surname>Potapov</surname><given-names>A.</given-names></name>, <name><surname>Yau</surname><given-names>W. M.</given-names></name>, <name><surname>Ghirlando</surname><given-names>R.</given-names></name>, <name><surname>Thurber</surname><given-names>K. R.</given-names></name> &amp; <name><surname>Tycko</surname><given-names>R.</given-names></name>
<article-title>Successive Stages of Amyloid-beta Self-Assembly Characterized by Solid-State Nuclear Magnetic Resonance with Dynamic Nuclear Polarization</article-title>. <source>J Am Chem Soc</source>
<volume>137</volume>, <fpage>8294</fpage>â<lpage>8307</lpage>, <pub-id pub-id-type="doi">10.1021/jacs.5b04843</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">26068174</pub-id></mixed-citation>
      </ref>
      <ref id="b57">
        <mixed-citation publication-type="journal"><name><surname>Dulin</surname><given-names>F.</given-names></name>
<italic>et al.</italic>
<article-title>P3 peptide, a truncated form of A beta devoid of synaptotoxic effect, does not assemble into soluble oligomers</article-title>. <source>FEBS Lett</source>
<volume>582</volume>, <fpage>1865</fpage>â<lpage>1870</lpage>, <pub-id pub-id-type="doi">10.1016/j.febslet.2008.05.002</pub-id> (<year>2008</year>).<pub-id pub-id-type="pmid">18474239</pub-id></mixed-citation>
      </ref>
      <ref id="b58">
        <mixed-citation publication-type="journal"><name><surname>Walsh</surname><given-names>D. M.</given-names></name>
<italic>et al.</italic>
<article-title>Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation <italic>in vivo</italic></article-title>. <source>Nature</source>
<volume>416</volume>, <fpage>535</fpage>â<lpage>539</lpage>, <pub-id pub-id-type="doi">10.1038/416535a</pub-id> (<year>2002</year>).<pub-id pub-id-type="pmid">11932745</pub-id></mixed-citation>
      </ref>
      <ref id="b59">
        <mixed-citation publication-type="journal"><name><surname>Di Fede</surname><given-names>G.</given-names></name>
<italic>et al.</italic>
<article-title>A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis</article-title>. <source>Science</source>
<volume>323</volume>, <fpage>1473</fpage>â<lpage>1477</lpage>, <pub-id pub-id-type="doi">10.1126/science.1168979</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19286555</pub-id></mixed-citation>
      </ref>
      <ref id="b60">
        <mixed-citation publication-type="journal"><name><surname>Ono</surname><given-names>K.</given-names></name>, <name><surname>Condron</surname><given-names>M. M.</given-names></name> &amp; <name><surname>Teplow</surname><given-names>D. B.</given-names></name>
<article-title>Effects of the English (H6R) and Tottori (D7N) Familial Alzheimer Disease Mutations on Amyloid beta-Protein Assembly and Toxicity</article-title>. <source>J Biol Chem</source>
<volume>285</volume>, <fpage>23184</fpage>â<lpage>23195</lpage>, <pub-id pub-id-type="doi">10.1074/jbc.M109.086496</pub-id> (<year>2010</year>).</mixed-citation>
      </ref>
      <ref id="b61">
        <mixed-citation publication-type="journal"><name><surname>Gardberg</surname><given-names>A. S.</given-names></name>
<italic>et al.</italic>
<article-title>Molecular basis for passive immunotherapy of Alzheimerâs disease</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>104</volume>, <fpage>15659</fpage>â<lpage>15664</lpage>, <pub-id pub-id-type="doi">10.1073/pnas.0705888104</pub-id> (<year>2007</year>).<pub-id pub-id-type="pmid">17895381</pub-id></mixed-citation>
      </ref>
      <ref id="b62">
        <mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>Y.</given-names></name>, <name><surname>Ma</surname><given-names>B.</given-names></name> &amp; <name><surname>Nussinov</surname><given-names>R.</given-names></name>
<article-title>Metal binding sites in amyloid oligomers: Complexes and mechanisms</article-title>. <source>Coord Chem Rev</source>
<volume>256</volume>, <fpage>2245</fpage>â<lpage>2252</lpage>, <pub-id pub-id-type="doi">10.1016/j.ccr.2011.12.022</pub-id> (<year>2012</year>).</mixed-citation>
      </ref>
      <ref id="b63">
        <mixed-citation publication-type="journal"><name><surname>Talmard</surname><given-names>C.</given-names></name>, <name><surname>Leuma Yona</surname><given-names>R.</given-names></name> &amp; <name><surname>Faller</surname><given-names>P.</given-names></name>
<article-title>Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein(1â28)</article-title>. <source>J Biol Inorg Chem</source>
<volume>14</volume>, <fpage>449</fpage>â<lpage>455</lpage>, <pub-id pub-id-type="doi">10.1007/s00775-008-0461-9</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19083027</pub-id></mixed-citation>
      </ref>
      <ref id="b64">
        <mixed-citation publication-type="journal"><name><surname>Alies</surname><given-names>B.</given-names></name>, <name><surname>Solari</surname><given-names>P. L.</given-names></name>, <name><surname>Hureau</surname><given-names>C.</given-names></name> &amp; <name><surname>Faller</surname><given-names>P.</given-names></name>
<article-title>Dynamics of Zn(II) binding as a key feature in the formation of amyloid fibrils by Abeta11-28</article-title>. <source>Inorg Chem</source>
<volume>51</volume>, <fpage>701</fpage>â<lpage>708</lpage>, <pub-id pub-id-type="doi">10.1021/ic202247m</pub-id> (<year>2012</year>).<pub-id pub-id-type="pmid">22148916</pub-id></mixed-citation>
      </ref>
      <ref id="b65">
        <mixed-citation publication-type="journal"><name><surname>Barnham</surname><given-names>K. J.</given-names></name>
<italic>et al.</italic>
<article-title>Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimerâs disease</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>105</volume>, <fpage>6813</fpage>â<lpage>6818</lpage>, <pub-id pub-id-type="doi">10.1073/pnas.0800712105</pub-id> (<year>2008</year>).<pub-id pub-id-type="pmid">18463291</pub-id></mixed-citation>
      </ref>
      <ref id="b66">
        <mixed-citation publication-type="journal"><name><surname>Toropygin</surname><given-names>I. Y.</given-names></name>
<italic>et al.</italic>
<article-title>The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimerâs Abeta-(1â16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry</article-title>. <source>Rapid Commun. Mass Spectrom.</source>
<volume>22</volume>, <fpage>231</fpage>â<lpage>239</lpage>, <pub-id pub-id-type="doi">10.1002/rcm.3357</pub-id> (<year>2008</year>).<pub-id pub-id-type="pmid">18085519</pub-id></mixed-citation>
      </ref>
      <ref id="b67">
        <mixed-citation publication-type="journal"><name><surname>Tsvetkov</surname><given-names>P. O.</given-names></name>
<italic>et al.</italic>
<article-title>Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral beta-Amyloidosis in A beta PP/PS1 Transgenic Mice</article-title>. <source>Journal of Alzheimers Disease</source>
<volume>46</volume>, <fpage>849</fpage>â<lpage>853</lpage>, <pub-id pub-id-type="doi">10.3233/Jad-150031</pub-id> (<year>2015</year>).</mixed-citation>
      </ref>
      <ref id="b68">
        <mixed-citation publication-type="journal"><name><surname>Delaglio</surname><given-names>F.</given-names></name>
<italic>et al.</italic>
<article-title>NMRPipe: a multidimensional spectral processing system based on UNIX pipes</article-title>. <source>J. Biomol. NMR</source>
<volume>6</volume>, <fpage>277</fpage>â<lpage>293</lpage>, <pub-id pub-id-type="doi">10.1007/BF00197809</pub-id> (<year>1995</year>).<pub-id pub-id-type="pmid">8520220</pub-id></mixed-citation>
      </ref>
      <ref id="b69">
        <mixed-citation publication-type="other"><name><surname>Goddard</surname><given-names>T. D.</given-names></name> &amp; <name><surname>Kneller</surname><given-names>D. G.</given-names></name>, Sparky - NMR Assignment and Integration Software (2008) Date of access: 07/01/2016, <ext-link ext-link-type="uri" xlink:href="http://www.cgl.ucsf.edu/home/sparky">http://www.cgl.ucsf.edu/home/sparky</ext-link>.</mixed-citation>
      </ref>
      <ref id="b70">
        <mixed-citation publication-type="journal"><name><surname>Van Der Spoel</surname><given-names>D.</given-names></name>
<italic>et al.</italic>
<article-title>GROMACS: fast, flexible and free</article-title>. <source>J. Comput. Chem.</source>
<volume>26</volume>, <fpage>1701</fpage>â<lpage>1718</lpage>, <pub-id pub-id-type="doi">10.1002/jcc.20291</pub-id> (<year>2005</year>).<pub-id pub-id-type="pmid">16211538</pub-id></mixed-citation>
      </ref>
      <ref id="b71">
        <mixed-citation publication-type="journal"><name><surname>Hornak</surname><given-names>V.</given-names></name>
<italic>et al.</italic>
<article-title>Comparison of multiple Amber force fields and development of improved protein backbone parameters</article-title>. <source>Proteins</source>
<volume>65</volume>, <fpage>712</fpage>â<lpage>725</lpage>, <pub-id pub-id-type="doi">10.1002/prot.21123</pub-id> (<year>2006</year>).<pub-id pub-id-type="pmid">16981200</pub-id></mixed-citation>
      </ref>
      <ref id="b72">
        <mixed-citation publication-type="journal"><name><surname>Biswas</surname><given-names>P. K.</given-names></name>
<article-title>A regularized and renormalized electrostatic coupling Hamiltonian for hybrid quantum-mechanical/molecular-mechanical calculations</article-title>. <source>J. Chem. Phys.</source>
<volume>123</volume>, <fpage>164114</fpage>, <pub-id pub-id-type="doi">10.1063/1.2064907</pub-id> (<year>2005</year>).<pub-id pub-id-type="pmid">16268688</pub-id></mixed-citation>
      </ref>
      <ref id="b73">
        <mixed-citation publication-type="journal"><name><surname>Laio</surname><given-names>A.</given-names></name>
<article-title>A Hamiltonian electrostatic coupling scheme for hybrid Car-Parrinello molecular dynamics simulations</article-title>. <source>J. Chem. Phys.</source>
<volume>116</volume>, <fpage>6941</fpage>, <pub-id pub-id-type="doi">10.1063/1.1462041</pub-id> (<year>2002</year>).</mixed-citation>
      </ref>
      <ref id="b74">
        <mixed-citation publication-type="journal"><name><surname>Laskowski</surname><given-names>R. A.</given-names></name>, <name><surname>Rullmannn</surname><given-names>J. A.</given-names></name>, <name><surname>MacArthur</surname><given-names>M. W.</given-names></name>, <name><surname>Kaptein</surname><given-names>R.</given-names></name> &amp; <name><surname>Thornton</surname><given-names>J. M.</given-names></name>
<article-title>AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR</article-title>. <source>J. Biomol. NMR</source>
<volume>8</volume>, <fpage>477</fpage>â<lpage>486</lpage>, <pub-id pub-id-type="doi">10.1007/BF00228148</pub-id> (<year>1996</year>).<pub-id pub-id-type="pmid">9008363</pub-id></mixed-citation>
      </ref>
      <ref id="b75">
        <mixed-citation publication-type="journal"><name><surname>Pettersen</surname><given-names>E. F.</given-names></name>
<italic>et al.</italic>
<article-title>UCSF chimeraâA visualization system for exploratory research and analysis</article-title>. <source>J Comput Chem</source>
<volume>25</volume>, <fpage>1605</fpage>â<lpage>1612</lpage>, <pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id> (<year>2004</year>).<pub-id pub-id-type="pmid">15264254</pub-id></mixed-citation>
      </ref>
      <ref id="b76">
        <mixed-citation publication-type="journal"><name><surname>Jakalian</surname><given-names>A.</given-names></name>, <name><surname>Bush</surname><given-names>B. L.</given-names></name>, <name><surname>Jack</surname><given-names>D. B.</given-names></name> &amp; <name><surname>Bayly</surname><given-names>C. I.</given-names></name>
<article-title>Fast, efficient generation of high-quality atomic Charges. AM1-BCC model: I. Method</article-title>. <source>J Comput Chem</source>
<volume>21</volume>, <fpage>132</fpage>â<lpage>146</lpage>, <pub-id pub-id-type="doi">10.1002/(Sici)1096-987x(20000130)21:2&lt;132::Aid-Jcc5&gt;3.3.Co;2-G</pub-id> (<year>2000</year>).</mixed-citation>
      </ref>
      <ref id="b77">
        <mixed-citation publication-type="journal"><name><surname>Lindorff-Larsen</surname><given-names>K.</given-names></name>
<italic>et al.</italic>
<article-title>Improved side-chain torsion potentials for the Amber ff99SB protein force field</article-title>. <source>Proteins</source>
<volume>78</volume>, <fpage>1950</fpage>â<lpage>1958</lpage>, <pub-id pub-id-type="doi">10.1002/prot.22711</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20408171</pub-id></mixed-citation>
      </ref>
      <ref id="b78">
        <mixed-citation publication-type="journal"><name><surname>Jorgensen</surname><given-names>W. L.</given-names></name>, <name><surname>Chandrasekhar</surname><given-names>J.</given-names></name>, <name><surname>Madura</surname><given-names>J. D.</given-names></name>, <name><surname>Impey</surname><given-names>R. W.</given-names></name> &amp; <name><surname>Klein</surname><given-names>M. L.</given-names></name>
<article-title>Comparison of Simple Potential Functions for Simulating Liquid Water</article-title>. <source>J. Chem. Phys.</source>
<volume>79</volume>, <fpage>926</fpage>â<lpage>935</lpage>, <pub-id pub-id-type="doi">10.1063/1.445869</pub-id> (<year>1983</year>).</mixed-citation>
      </ref>
      <ref id="b79">
        <mixed-citation publication-type="journal"><name><surname>Darden</surname><given-names>T.</given-names></name>, <name><surname>York</surname><given-names>D.</given-names></name> &amp; <name><surname>Pedersen</surname><given-names>L.</given-names></name>
<article-title>Particle Mesh Ewald - an N.Log(N) Method for Ewald Sums in Large Systems</article-title>. <source>J. Chem. Phys.</source>
<volume>98</volume>, <fpage>10089</fpage>â<lpage>10092</lpage>, <pub-id pub-id-type="doi">10.1063/1.464397</pub-id> (<year>1993</year>).</mixed-citation>
      </ref>
      <ref id="b80">
        <mixed-citation publication-type="journal"><name><surname>Hess</surname><given-names>B.</given-names></name>, <name><surname>Bekker</surname><given-names>H.</given-names></name>, <name><surname>Berendsen</surname><given-names>H. J. C.</given-names></name> &amp; <name><surname>Fraaije</surname><given-names>J. G. E. M.</given-names></name>
<article-title>LINCS: A linear constraint solver for molecular simulations</article-title>. <source>J. Comput. Chem.</source>
<volume>18</volume>, <fpage>1463</fpage>â<lpage>1472</lpage>, <pub-id pub-id-type="doi">10.1002/(sici)1096-987x(199709)18:12&lt;1463::aid-jcc4&gt;3.0.co;2-h</pub-id> (<year>1997</year>).</mixed-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p><bold>Author Contributions</bold> S.A.K., A.A.M., A.P. and V.I.P. designed the research and wrote the manuscript; A.P. and S.S.Z. performed the NMR experiments; O.I.K. performed D.L.S. and I.T.C. experiments, A.N.I., O.I.K. and V.I.P. performed data analysis; A.N.I. and A.B.M. performed the M.D. and Q.M.-M.M. calculations.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="f1">
      <label>Figure 1</label>
      <caption>
        <title>Amino acid sequences of the studied ÐÎ² fragments.</title>
      </caption>
      <graphic xlink:href="srep21734-f1"/>
    </fig>
    <fig id="f2">
      <label>Figure 2</label>
      <caption>
        <p>Fragments of NOESY spectra (mixing time 250âms) of free peptides (<bold>a</bold>) ÐÎ²<sub>1â16</sub>, (<bold>b</bold>) H6R-ÐÎ²<sub>1â16</sub>, and (<bold>c</bold>) isoD7-ÐÎ²<sub>1â16</sub> illustrating similar patterns of sequential and medium-range NOEs with the participation of the methyl groups of V12. Spectra were recorded in 90% H<sub>2</sub>O/10% D<sub>2</sub>O, in presence of 10âmM bis-tris-d<sub>19</sub>, pH 6.8, at 283K.</p>
      </caption>
      <graphic xlink:href="srep21734-f2"/>
    </fig>
    <fig id="f3">
      <label>Figure 3</label>
      <caption>
        <p>Fragments of 1D spectra of ÐÎ²<sub>1â16</sub> (<bold>A</bold>), H6R-ÐÎ²<sub>1â16</sub> (<bold>B</bold>), and <sup>Ac</sup>isoD7-ÐÎ²<sub>1â16</sub> (<bold>C</bold>) in the presence of half molar equivalence of Zn<sup>2+</sup>. Peptide concentration is ~0.2âmM. Spectra were recorded at 283K in 90% H<sub>2</sub>O/10% D<sub>2</sub>O in the presence of 10âmM bis-Trid-d<sub>19</sub> buffer, pH 6.8 at 283K. Characteristic signal at ~0.2 ppm belongs to the methyl group HÎ³1* of V12 in dimeric complex. Content of the dimer at ~0.2âmM total concentration of the peptides is about 5%.</p>
      </caption>
      <graphic xlink:href="srep21734-f3"/>
    </fig>
    <fig id="f4">
      <label>Figure 4</label>
      <caption>
        <title>Fragment of the ROESY spectrum (mixing time 100âms) of the <sup>Ac</sup>H6R-ÐÎ²<sub>1â16</sub> in the presence of half molar equivalence of Zn<sup>2+</sup> recorded at 283âK in D<sub>2</sub>O in the presence of 10âmM bis-Trid-d<sub>19</sub> buffer, pH 6.8.</title>
        <p>The peptide concentration ~2.5âmM. Cross-peaks with positive intensity (red) correspond to the exchange signals between monomer and dimer. Negative (blue) cross-peaks correspond to NOE correlations.</p>
      </caption>
      <graphic xlink:href="srep21734-f4"/>
    </fig>
    <fig id="f5">
      <label>Figure 5</label>
      <caption>
        <title>Fragment of the NOESY spectrum (mixing time 250âms) of the <sup>Ac</sup>H6R-ÐÎ²<sub>1â16</sub> in the presence of half molar equivalence of Zn<sup>2+</sup> recorded at 274âK in 90%H<sub>2</sub>O/10%D<sub>2</sub>O, 10âmM bis-Trid-d<sub>19</sub> buffer, pH 6.8.</title>
        <p>The peptide concentration ~2.5âmM. Red arrows show sequential assignment pathway in the region of HNâHÎ± correlations. Blue lines indicate resonances of the representative signals of the dimer complex, green lines correspond to the signals of the monomeric zinc-peptide complex.</p>
      </caption>
      <graphic xlink:href="srep21734-f5"/>
    </fig>
    <fig id="f6">
      <label>Figure 6</label>
      <caption>
        <title>Structure of the representative conformer H6R-AÎ²<sub>1â16</sub> zinc-bound dimer after additional QM/MM refinement.</title>
        <p>Shown are backbone atoms of two polypeptide chains and side chains of the residues 10â14 involved in formation of zinc-induced dimerization interface. Solvent-accessible molecular surface is calculated for all atoms and colored according to the interpolated charge distribution.</p>
      </caption>
      <graphic xlink:href="srep21734-f6"/>
    </fig>
    <fig id="f7">
      <label>Figure 7</label>
      <caption>
        <p>Final conformations from the 20âns restrained molecular dynamic trajectories of the dimers (<bold>A</bold>) AÎ²<sub>1â16</sub>Â·AÎ²<sub>1â16</sub> and (<bold>B</bold>) isoD7-AÎ²<sub>1â16</sub>Â·AÎ²<sub>1â16</sub>. Restraint of 6âÃ has been applied to the distance between H6 NÎµ2 and H13 NÎµ2 atoms during MD simulations in order to keep positions of imidazole rings in conformation favorable for zinc binding. Residues H6, D7, isoD7, S8 and H13 are shown by bold sticks.</p>
      </caption>
      <graphic xlink:href="srep21734-f7"/>
    </fig>
    <fig id="f8">
      <label>Figure 8</label>
      <caption>
        <title>Cartoon representation of the zinc-induced oligomerization of the AÎ² metal binding domain.</title>
        <p>Tubes represent AÎ²<sub>1â16</sub>, isoD7-AÎ²<sub>1â16</sub> and AÎ²<sub>6â16</sub> fragments. Zinc ions are shown as gray circles. Shown are stages of oligomerization: (<bold>a</bold>) peptide in free state, (<bold>b</bold>) peptide in complex with zinc ion, (<bold>c</bold>) zinc-induced peptide dimer, and (<bold>d</bold>) zinc-induced peptide oligomer formed around the dimer. Oligomerization seed (peptide dimer) is highlighted by pink.</p>
      </caption>
      <graphic xlink:href="srep21734-f8"/>
    </fig>
    <table-wrap position="float" id="t1">
      <label>Table 1</label>
      <caption>
        <title>Parameters of zinc binding to the peptides measured by ITC or NMR, mean diameter of oligomers in the absence and presence of twofold molar excess of ZnCl<sub>2</sub> measured by dynamic light scattering, and turbidity of the solutions.</title>
      </caption>
      <table frame="hsides" rules="groups" border="1">
        <colgroup>
          <col align="left"/>
          <col align="center"/>
          <col align="center"/>
          <col align="center"/>
          <col align="center"/>
          <col align="center"/>
          <col align="center"/>
          <col align="center"/>
        </colgroup>
        <thead valign="bottom">
          <tr>
            <th rowspan="2" align="left" valign="top" charoff="50">Peptides</th>
            <th colspan="3" align="center" valign="top" charoff="50">Zinc binding<hr/></th>
            <th rowspan="2" align="center" valign="top" charoff="50">C, mM</th>
            <th align="center" valign="top" charoff="50">DLS</th>
            <th colspan="2" align="center" valign="top" charoff="50">Turbidity<xref ref-type="fn" rid="t1-fn3">c</xref> OD<sub>350</sub>âÃâ10<sup>2</sup>/OD<sub>405</sub>âÃâ10<sup>2</sup><hr/></th>
          </tr>
          <tr>
            <th align="center" valign="top" charoff="50">K<sub>a</sub>âÃâ10<sup>4</sup>, M<sup>â1</sup></th>
            <th align="center" valign="top" charoff="50">N<xref ref-type="fn" rid="t1-fn1">a</xref></th>
            <th align="center" valign="top" charoff="50">Ref</th>
            <th align="center" valign="top" charoff="50">Diameter, nm<xref ref-type="fn" rid="t1-fn2">b</xref></th>
            <th align="center" valign="top" charoff="50">Free peptide</th>
            <th align="center" valign="top" charoff="50">Peptideâ+âZnCl<sub>2</sub></th>
          </tr>
        </thead>
        <tbody valign="top">
          <tr>
            <td rowspan="2" align="left" valign="top" charoff="50">AÎ²<sub>1â16</sub></td>
            <td align="center" valign="top" charoff="50">1.70âÂ±â0.40</td>
            <td align="center" valign="top" charoff="50">1.0</td>
            <td align="center" valign="top" charoff="50">ITC <xref ref-type="bibr" rid="b43">43</xref></td>
            <td align="center" valign="top" charoff="50">0.2</td>
            <td align="center" valign="top" charoff="50">0</td>
            <td align="center" valign="top" charoff="50">2.2âÂ±â1.3/2.2âÂ±â1.8</td>
            <td align="center" valign="top" charoff="50">3.0âÂ±â1.7/1.8âÂ±â0.9</td>
          </tr>
          <tr>
            <td align="center" valign="top" charoff="50">Â </td>
            <td align="center" valign="top" charoff="50">Â </td>
            <td align="center" valign="top" charoff="50">Â </td>
            <td align="center" valign="top" charoff="50">5.0</td>
            <td align="center" valign="top" charoff="50">2.5âÂ±â0.3</td>
            <td align="center" valign="top" charoff="50">9.4âÂ±â1.7/5.4âÂ±â1.1</td>
            <td align="center" valign="top" charoff="50">44âÂ±â10/38âÂ±â10</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">H6R-AÎ²<sub>1â16</sub></td>
            <td align="center" valign="top" charoff="50">0.24âÂ±â0.03</td>
            <td align="center" valign="top" charoff="50">0.5</td>
            <td align="center" valign="top" charoff="50">ITC<xref ref-type="bibr" rid="b36">36</xref></td>
            <td align="center" valign="top" charoff="50">1.0</td>
            <td align="center" valign="top" charoff="50">0</td>
            <td align="center" valign="top" charoff="50">1.5âÂ±â0.6/1.7âÂ±â0.9</td>
            <td align="center" valign="top" charoff="50">2.0âÂ±â1.2/1.9âÂ±â1.3</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">isoD7-AÎ²<sub>1â16</sub></td>
            <td align="center" valign="top" charoff="50">1.30âÂ±â0.40</td>
            <td align="center" valign="top" charoff="50">1.0</td>
            <td align="center" valign="top" charoff="50">ITC <xref ref-type="bibr" rid="b43">43</xref></td>
            <td align="center" valign="top" charoff="50">0.8</td>
            <td align="center" valign="top" charoff="50">2.7âÂ±â0.3</td>
            <td align="center" valign="top" charoff="50">2.4âÂ±â1.1/2.4âÂ±â1.1</td>
            <td align="center" valign="top" charoff="50">491âÂ±â232/454âÂ±â219</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">AÎ²<sub>6â16</sub></td>
            <td align="center" valign="top" charoff="50">1.27âÂ±â0.13</td>
            <td align="center" valign="top" charoff="50">1.0</td>
            <td align="center" valign="top" charoff="50">this work, ITC</td>
            <td align="center" valign="top" charoff="50">2.0</td>
            <td align="center" valign="top" charoff="50">17âÂ±â6</td>
            <td align="center" valign="top" charoff="50">2.0âÂ±â0.8/2.2âÂ±â0.8</td>
            <td align="center" valign="top" charoff="50">422âÂ±â20/278âÂ±â11</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">isoD7-H13R-AÎ²<sub>1â16</sub></td>
            <td align="center" valign="top" charoff="50">0.14âÂ±â0.01</td>
            <td align="center" valign="top" charoff="50">1.0</td>
            <td align="center" valign="top" charoff="50">this work, NMR</td>
            <td align="center" valign="top" charoff="50">1.0</td>
            <td align="center" valign="top" charoff="50">0</td>
            <td align="center" valign="top" charoff="50">1.7âÂ±â1.1/1.4âÂ±â1.0</td>
            <td align="center" valign="top" charoff="50">2.0âÂ±â1.3/2.0âÂ±â1.1</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">isoD7-AÎ²<sub>1â10</sub></td>
            <td align="center" valign="top" charoff="50">0.12âÂ±â0.01</td>
            <td align="center" valign="top" charoff="50">1.0</td>
            <td align="center" valign="top" charoff="50">this work, NMR</td>
            <td align="center" valign="top" charoff="50">1.0</td>
            <td align="center" valign="top" charoff="50">0</td>
            <td align="center" valign="top" charoff="50">2.6âÂ±â1.4/2.5âÂ±â1.1</td>
            <td align="center" valign="top" charoff="50">2.8âÂ±â1.7/2.8âÂ±â1.3</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="t1-fn1">
          <p>Concentration of the peptides in DLS and turbidity measurements are shown.</p>
        </fn>
        <fn id="t1-fn2">
          <p><sup>a</sup>N â stoichiometry.</p>
        </fn>
        <fn id="t1-fn3">
          <p><sup>b</sup>Mean diameter of oligomers determined by DLS.</p>
        </fn>
        <fn id="t1-fn4">
          <p><sup>c</sup>OD<sub>350</sub> and OD<sub>405</sub> â optical density of the peptide solutions measured at 350ânm and 405ânm.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap position="float" id="t2">
      <label>Table 2</label>
      <caption>
        <title>NMR restrains and structural statistics for the complex of two H6R-AÎ²<sub>1â16</sub> peptides with zinc ion.</title>
      </caption>
      <table frame="hsides" rules="groups" border="1">
        <colgroup>
          <col align="left"/>
          <col align="center"/>
        </colgroup>
        <tbody valign="top">
          <tr>
            <td align="left" valign="top" charoff="50">Number of NOE restrains</td>
            <td align="center" valign="top" charoff="50">181</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">âIntra-residue</td>
            <td align="center" valign="top" charoff="50">91</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">âSequential</td>
            <td align="center" valign="top" charoff="50">55</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">âMedium-range</td>
            <td align="center" valign="top" charoff="50">23</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">âLong-range (|i-j|â&gt;â4)</td>
            <td align="center" valign="top" charoff="50">4</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">âDistance constraints of Zn<sup>2+</sup> chelating center</td>
            <td align="center" valign="top" charoff="50">8</td>
          </tr>
          <tr>
            <td colspan="2" align="left" valign="top" charoff="50">Ramachandran map statistics</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â% of residues in most favorable region of Ramachandran map</td>
            <td align="center" valign="top" charoff="50">73.5</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â% of residues in disallowed region of Ramachandran map</td>
            <td align="center" valign="top" charoff="50">0.0</td>
          </tr>
          <tr>
            <td colspan="2" align="left" valign="top" charoff="50">NMR family statistics</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">âNumber of conformers in family of structure</td>
            <td align="center" valign="top" charoff="50">20</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">âNumber of distance violations (&gt;0.5âÃ) per structure</td>
            <td align="center" valign="top" charoff="50">&lt;1</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">âBackbone (C, CÎ± and N) rmsd of residues 1â16 (Ã)</td>
            <td align="center" valign="top" charoff="50">2.31âÂ±â0.55</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">âBackbone (C, CÎ± and N) rmsd of residues 6 â 15 (Ã)</td>
            <td align="center" valign="top" charoff="50">1.39âÂ±â0.36</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">âBackbone (C, CÎ± and N) rmsd of residues 8 â 15 and all heavy atoms of residues 11 and 14 (Ã)</td>
            <td align="center" valign="top" charoff="50">1.08âÂ±â0.26</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>